international journal of scientific and innovative research 2013; 1(1)p issn 2347-2189, e- issn...
TRANSCRIPT
VOLUME – 1, ISSUE – 1 (JANUARY - JUNE) 2013
Editorial
I am happy to convey that second issue of third volume of "International Journal of Scientific and
Innovative Research (IJSIR)", a bi-annual journal has been published by Sky Institute, Lucknow in an
effort to promote multidisciplinary scientific and innovative research of societal benefit. This journal
covers all branches of science, technology, engineering, health, agriculture and management.
Research articles in the field of education are also encouraged in order to promote educational
technology aiming at improvement in present educational system. As research and development (R &
D) has been playing a significant role in overall development of society, continuous multidisciplinary
innovative research in science and technology is needed to address the challenges in context to
changing environmental conditions in the present era of gradual increase in industrial and
technological advancement at global level. Efforts should be made to develop eco-friendly
technologies in order to provide solutions for developing socially, economically and culturally
sustainable society.
The present issue of International Journal of Scientific and Innovative Research (IJSIR) contains 6
research papers I articles covering different areas of science and technology. All these papers are well
written and informative in content. I express my sincere thanks and gratefulness to Mr.Mohit Bajpai,
Chairman, Sky Institute, Lucknow (U.P.), India for his support in publishing it. I express my thanks to
members of Committee for Editorial Assistance Dr. B.C.Tripathi, Dr. Pankaj Verma, Shri Sanjay
Pandey, Shri Sanjay Dixit and Mr. Shamshul Hasan Khan for their hard work and devotion in giving
the final shape to the journal. I am thankful to all faculty members, scientists and research scholars of
different universities, research organizations and technical institutions for contributing their research
articles for publication in the present issue of the journal. The help provided by faculty members and
supporting staff of Sky Institute in publishing the present volume of the journal is also acknowledged. I
hope scientists, academicians and young researchers will be greatly benefited by this publication for
their research work.
I request humbly to the readers and contributors of our journal to continue encouraging us for regular
publication of the journal. Any suggestion and comment for the improvement in the quality of the
journal are always welcome.
Dr. B. R. Pandey
Editor-in-Chief
International Journal of Scientific and Innovative Research 2013; 1(1) P-ISSN 2347-2189, E- ISSN 2347-4971
www.ijsir.co.in 163
DR. B.R. PANDEY
DIRECTOR (RESEARCH)SKY INSTITUTE, KURSI ROAD, LUCKNOW, U.P, INDIA
FORMER JOINT DIRECTOR, COUNCIL OF SCIENCE & TECHNOLOGY, UP, LUCKNOW
(DEPARTMENT OF SCIENCE AND TECHNOLOGY, UP GOVERNMENT), INDIA
FORMER PROFESSOR, INTERNATIONAL INSTITUTE OF HERBAL MEDICINE (IIHM), LUCKNOW, U.P., INDIA
E-MAIL ID: [email protected], MOBILE-: 9794849800
Dr. B.C.TripathiAssistant Prof.
Deptt. of Educa-
tion,
Rama P.G. College,
Chinhat, Lucknow,
Uttar Pradesh
Dr. Pankaj Verma
Senior Research Fellow,
Deptt. of Oral & Maxillofacial
Surgery,
Faculty of Dental Sciences,
K.G. Medical University,
Lucknow, Uttar Pradesh
Shri Sanjay Pandey Assistant Prof.
National Institute of
Fashion Technology,
Raebareli,
Uttar Pradesh
Shri Ashish TiwariResearch Scholar,
Sai Nath University,
Ranchi,
Jharkhand
ADVISORY BOARD
EDITOR-IN-CHIEF
COMMITTEE FOR EDITORIAL ASSISTANCE
Prof.(Dr.)S. P. OjhaFormer Vice Chancellor, CCS Meerut University, Meerut, Uttar Pradesh
Prof.(Dr.)V.K. SrivastavaFormer Prof & Head, Deptt. of Community Medicine
King George Medical University, Lucknow.
Former Director, Integral Institute of Medical Sciences & Research,
Integral University, Lucknow
Former Vice -Chancellor,
Texila American University, Georgetown, Guyana, South America
Prof.(Dr.) M.I. KhanProf & Head, Deptt. of Mechanical Engg.,
Integral University, Lucknow, Uttar Pradesh
Prof. (Dr.) S.K. AvasthiFormer Director, H.B.T.I., Kanpur, Uttar Pradesh
Prof.(Dr.) Amrika SinghProf & Head (Chemistry), Deptt. of Applied Sciences,
Institute of Engg. & Technology, Sitapur Road, Lucknow, Uttar Pradesh
Prof.(Dr.) U.N. DwivediProf & Ex- Head, Deptt of Biochemistry, Former Pro- Vice Chancellor,
Former Dean, Faculty of Science, University of Lucknow, Lucknow, U.P.
Prof.(Dr.) U.K. MisraHead, Deptt. of Neurology, Ex Dean,
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, U.P.
Dr. A.K. GuptaFormer Deputy Director General,
Indian Council of Medical Research (ICMR), Ansari Nagar, New Delhi
Prof.(Dr.) V.K.TondonFormer Prof & Head, Deptt. of Chemistry, Ex- Dean Faculty of Science,
University of Lucknow, Lucknow, Uttar Pradesh
Prof. (Dr.) Amod Kumar Tiwari,Prof.- Director, Bhabha Institute of Engg.& Technology, Kanpur, U.P.
Prof.(Dr.) Chandra Dhar DwivediFormer Prof. & Chairman, Deptt. of Pharmaceutical Sciences, College of
Pharmacy, South Dakota State University, Borokings, South Dakota, USA
Prof.(Dr.) Vimal KishoreProf. & Chairman, Deptt. of Basic Pharmaceutical Sciences,
Xevier College of Pharmacy, University of Louisiana, 7325,
Palmetto Street New Orlens, Louisiana USA
Prof .(Dr.) M.C. Pant,Former Director,R. M. L. Institute of Medical Sciences, Lucknow and Prof. & Head,Deptt. of Radiotherapy, K. G. Medical University, Lucknow, Uttar Pradesh
Prof. (Dr.) S.P. SinghFormer Prof & Head, Deptt. of Pharmacology,
G. S. V. M. Medical College, Kanpur, Uttar Pradesh
Prof. (Dr.) R. L. SinghProf & Head, Department of Biochemistry & Coordinator Biotechnology
Program , Dr. R. M. L. University Faizabad, Uttar Pradesh
Dr. Sarita VermaHead, Deptt. of Home Sci., Mahila P.G. College, Kanpur, Uttar Pradesh
Prof. (Dr.) S.K.AgarwalPro. & Ex-Head, Deptt. of Biochemistry, Lucknow University,
Lucknow, U.P.
Dr. Bharat SahDirector,
National Institute of Fashion Technology, Raebareli, Uttar Pradesh
Prof.(Dr.)N.S. VermaProf., Deptt. of Physiology,
K. G. Medical University, Lucknow, Uttar Pradesh
Prof.(Dr.)A.K. TripathiProf. & Head, Deptt. of Clinical Hematology & Medical Oncology,
K. G. Medical University, Lucknow, Uttar Pradesh
Prof.(Dr.)C.M. PandeyProf. & Head, Deptt. of Biostatistics & Health Informatics,
Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar
Pradesh
Dr. Rupesh ChaturvediAssociate Prof., School of Biotechnology,
Jawaharlal Nehru University, New Delhi, Former Asstt. Prof., Deptt. of
Pharmaceutical Sciences , College of Pharmacy, Vanderbilt University,
Tennessee, USA
Dr. S.SinhaAsstt. Prof. Deptt. of Internal Medicine, CD University,
C. David Giffen School of Medi., University of California, Los Angeles, USA
Dr. K.RamanPrincipal Scientist, Martek Biosciences Corporation,
6480 Dobbin Road, Columbia, MD 21045, USA
Dr. P.K.AgarwalEditor –in – Chief, Natural Product Communication,
Natural Product Inc 7963, Anderson Park Lane West Terville, OH, USA
Dr. R.K.Singh,Chief Scientist, Division of Toxicology, CSIR-Central Drug Research
Institute, Jankipuram Extension, Lucknow, Uttar Pradesh
Dr. Mohd. TariqueProf., Deptt of Physical Edu., Lucknow University, Lucknow, Uttar Pradesh
1
Shri Sanjay DixitScientist,
Sky Institute
Lucknow
Uttar Pradesh
164 www.ijsir.co.in
International Journal of Scientific and Innovative Research 2013; 1(1) P-ISSN 2347-2189, E- ISSN 2347-4971
EDITORIAL BOARD
Prof.(Dr.) Y.B. TripathiProf. & Head, Deptt. of Medicinal Chemistry,Institute of Medical Sciences,Banaras Hindu University Varanasi, Uttar Pradesh
Prof.(Dr.) R.K. SinghProf. & Head , Deptt. of Biochemistry, Shri Guru Ram RaiInstitute of Medical &Health Sciences, Dehradun, Uttarakhand & Former Prof. & Head, Department ofBiochemistry, K. G. Medical University , Lucknow, U.P.
Prof. (Dr.) R.S.DiwediFormer Director, National Research Centre for Groundnut (NRCG) , ICAR,Junagarh, Gujarat & Former Principal Scientist – Head, Deptt. of PlantPhysiology, Indian Institute of Sugarcane Research, Lucknow, Uttar Pradesh
Prof. (Dr.) Nuzhat HusainProf. & Head , Deptt of Pathology & Acting Director, R. M. L. Institute ofMedical Sciences, Lucknow,Uttar Pradesh
Prof. (Dr.) Amita JainProf. Deptt. of Microbiology, K.G. Medical University, Lucknow, U.P.
Dr. Sudhir MahrotraAssociate Prof., Deptt. of Biochemistry, Lucknow University, Lucknow, U.P.
Prof. (Dr.) Vibha SinghProf., Deptt. of Oral & Maxillofacial Surgery, Faculty of Dental Sciences,K. G. Medical University, Lucknow, Uttar Pradesh
Prof. (Dr.) U.S. PalProf. & Head, Deptt. of Oral & Maxillofacial Surgery, Faculty of Dental Sciences,K. G. Medical University, Lucknow, Uttar Pradesh
Prof. (Dr. ) K.K. PantProf. & Head , Deptt. of Pharmacology & Therapeutics,K. G. Medical University, Lucknow, Uttar Pradesh
Dr. C.M.K.TripathiFormer Deputy Director & Head, Division of Fermentation Technology, CSIR-Central Drug Research Institute , Lucknow, Uttar Pradesh
Dr. R.D. TripathiChief Scientist & ProfessorPlant Ecology & Environmental Science Division,Uttar Pradesh CSIR-National Botanical Research Institute, Lucknow, U.P.
Prof.(Dr.) Ashwani K. SrivastavProf. & Head, Deptt. of Biosciences, Integral University,Lucknow,Former Senior Scientist, Birbal Sbahani Institute Paleobotany, Lucknow, U.P.
Prof.(Dr.) L. PandeyProf. & Head , Postgraduate Deptt . of Physics,Former Dean, Faculty of Science,Rani Durgawati University, Jabalpur, Madhya Pradesh, India
Prof .(Dr.) Bali RamProf., Deptt. of Chemistry, Banaras Hindu University, Varanasi, Uttar Pradesh
Prof.(Dr.) J.P.N.RaiProf.& Head, Deptt. of Environmental Sciences, G.B. Pant University of Agr. &Technology, Pant Nagar, Uttarakhand
Prof.(Dr. )R. S. DubeyProf. & Head, Deptt. of Biochemistry, Banaras Hindu University, Varanasi, U.P.
Prof. (Dr.) OmkarDeptt. of Zoology, Lucknow University, Lucknow, Uttar Pradesh
Prof.(Dr.) Sudhir KumarProf., Deptt. of Zoology, Lucknow University, Lucknow, Uttar Pradesh
Prof.(Dr.) Naveen KhareProf., Deptt. of Chemistry, Lucknow University, Lucknow, Uttar Pradesh
Prof.(Dr.) S. M. NatuProf., Deptt. of Pathalogy,K.G. Medical University, Lucknow, Uttar Pradesh
Dr. Kusum Lata Mishra,In-charge, Coagulation Laboratory, Deptt. of Pathology,
K.G. Medical University, Lucknow, Uttar Pradesh
Prof.(Dr.)V.K. Sharma,Prof., Deptt. of Chemistry, Lucknow University, Uttar Pradesh
Prof.(Dr.) R.K. ShuklaProf., Deptt. of Physics, Lucknow University, Lucknow Uttar Pradesh
Prof.(Dr.)Anil GaurProf., Deptt. of Biotechnology & Genetic Engg., G.B. Pant University of Agr. &Technology, Pant Nagar, Uttarakhand
Dr. Mahesh PalPrincipal Scientist ,Phytochemistry Division, CSIR- National Botanical ResearchInstitute, Lucknow, Uttar Pradesh
Dr. Vinod SinghAssoc. Prof. & Head, Deptt. of Microbiology, Baruktulla University, Bhopal,Madhya Pradesh
Dr. K.K.VermaAssoc. Prof., Deptt. of Physics & Electronics.Dr. R. M. L. Awadh University ,Faizabad,Uttar Pradesh
Dr. Atul GuptaSenior Scientist, CSIR- Central Institute of Medicinal & Aromatic Plants,Lucknow, Uttar Pradesh
Dr. Saudan Singh,Senior Principal Scientist,CSIR- Central Institute of Medicinal & Aromatic Plants ,Lucknow, Uttar Pradesh
Dr. S.K.TiwariSenior Principal Scientist ,CSIR- National Botanical Research Institute, Lucknow,Uttar Pradesh
Dr. Shivani Pandey,Asstt. Prof., Deptt. of Biochemistry,K.G.Medical University, Lucknow, U.P.
Dr. B.C. Yadav,Lucknow Associate Prof. & Coordinator, Deptt. of Applied Physics, School forPhysical Sciences, Babasaheb Bhimrao Ambedkar University, Lucknow, U.P.
Dr. Anchal Srivastava,Prof., Deptt of Physics, Lucknow University,Lucknow, Uttar Pradesh
Dr. Shalini BariarAsstt. Professor, Durga Devi Saraf Institute of Management, Mumbai, India
Dr.A.K.PandeyPrincipal Scientist, National Bureau of Fish Genetic Resources,Lucknow, U.P.
Dr.S.K.PandeyG.M. LML Factory, Kanpur Uttar Pradesh
Dr. Suneet Kumar Awasthi,Asst. Prof ,Deptt.of PhysicsJ.P. University, Noida, Uttar Pradesh
Dr.G. N. PandeyAsst. Prof, Deptt. of Physics Amity University, Noida ,Uttar Pradesh
Dr. Mukesh VermaAsst. Prof., Deptt. of Physical Education, Dr. R.M.L. Avadh University, Faizabad,Uttar Pradesh
Dr. Abhay Singh,Head, Physical Education, Delhi Public School, Lucknow Uttar Pradesh
Dr. Santosh GaurAsst. Prof. Deptt. of Physical Education, Jawahar Lal Nehru P.G. College,Barabanki, Uttar Pradesh
Dr.Sanjeev Kumar JhaSenior Scientist, DEOACC Patna
Dr. Shivlok SinghScientist, DEOACC, Lucknow, Uttar Pradesh
Dr. Anurag Tripathi,Asstt . Prof. , Deptt. of Electrical Engg., Institute of Engg. & Technology, SitapurRoad, Lucknow, Uttar Pradesh
Prof. V.P.SharmaSenior Principal Scientist, CSIR-Indian Institute of Toxicology Research,Lucknow, Uttar Pradesh
Dr. Krishna GopalFormer Deputy Director & Head , Aquatic Toxicology Division, CSIR- IndianInstitute of Toxicology Research, Lucknow, Uttar Pradesh
Dr. S.P. ShuklaProf. , Deptt. of Civil Engg., Institute of Engg. & Technology, Sitapur Road ,Lucknow, Uttar Pradesh
Dr. Ajay MishraAssociate Prof. , Deptt. of Geology, Lucknow University, Lucknow , U. P.
Dr. Ashutosh SinghProf., Deptt. of Chemistry,Saket P.G. College, Ayodhya, Faizabad, U. P.
Dr. S.K. SinghPrincipal, Gita College of Education , Nimbari, Panipat, Haryana
Shri Sudesh BhatAdvisor (Education), Sky Institute, Lucknow, Uttar Pradesh
Dr. Krishna GopalAsst. Prof., Deptt. of English,Rama University, Kanpur, Uttar Pradesh
2
International Journal of Scientific and Innovative Research 2013; 1(1) P-ISSN 2347-2189, E- ISSN 2347-4971
www.ijsir.co.in 165
ABOUT EDITOR-IN- CHIEF : DR. B. R. PANDEY
Dr. B. R. Pandey is a well known academician and scientist with brilliant academic career and
research accomplishments . He has done M.Sc. ( organic chemistry) from Banaras Hindu University,
Varanasi, India in the year 1972. He has done PhD in Medicinal Chemistry under the guidance of world
renowned Biochemist & Medicinal Chemist, Professor S.S. Parmar , Professor of Medicinal Chemistry &
Chemical Pharmacology, Department of Pharmacology & Therapeutics, K. G. Medical College, Lucknow (
Presently K. G. Medical University), Faculty of Medicine, University of Lucknow, Lucknow, India in the
year 1976. Dr. Pandey has all throughout first class educational qualifications and his research interest
covers medicinal chemistry, biochemical pharmacology, neurochemistry, neuro-toxicology, environmental
chemistry, herbal medicine & natural products. He is having extensive research experience of more than 40
years and published several research papers in peer reviewed journals of international repute. His research
particularly on the studies of central nervous system acting drugs and anti-inflammatory drugs and their
biochemical mode of action using animal models and enzymes such as monoamine oxidase, acetylcholine
esterase, purine catabolizing enzymes , proteolytic enzymes, membrane stabilizing enzymes, respiratory
enzymes, microsomal enzymes etc. has been well recognized as evidenced by his research publications .
Further, his research on developing herbal medicines has been found very useful in prevention and treatment
of chronic diseases and other refractory diseases for which modern system of medicine have no permanent
cure. He has worked on the position of Joint Director, Council of Science & Technology, U.P., Lucknow,
Department of Science & Technology, Uttar Pradesh Government, India from the year 1979 to 2011, where
he successfully executed several R & D projects in various disciplines of Science & Technology including
chemical & pharmaceutical sciences, medical sciences, biological sciences, environmental sciences etc.
During his tenure as Joint Director, he has been instrumental in launching and implementing important
schemes: Young Scientists Scheme, Young Scientist Visiting Fellowship Scheme, Establishment of Centre of
Excellence- Encephalitis Research Centre of Excellence in Sanjay Gandhi Post Graduate Institute of Medical
Sciences ( SGPGIMS), Lucknow , U. P. India ; Centre of Excellence in Materials Science ( nano materials)
in Z. H. College of Engg. & Technology, Aligarh Muslim University, Aligarh, U.P. India, Establishment of
Patent Information Centre in the premises of Council of Science & Technology , U.P. He has also worked
on the post of Secretary ( as additional charge ) , Council of Science & Technology, U.P. several times and
functioned as Administrative Head of the Organization. Prior to taking over the position of Joint Director,
Council of Science & Technology, U.P. in the year 1979, he has worked as Junior Research Fellow/ Senior
Research Fellow ( Council of Scientific & Industrial Research, New Delhi ), Assistant Research Officer (
Jawaharlal Nehru Laboratory of Molecular Biology) at Department of Pharmacology & Therapeutics, K.
G. Medical College ( presently K. G. Medical University), Faculty of Medicine, University of Lucknow,
Lucknow, India from the year 1972 to 1979 and involved in multidisciplinary biomedical research leading to
drug development . He has worked as Visiting Scientist / Faculty in the Department of Physiology, School
of Medicine, University of North Dakota, Grand Forks, North Dakota, USA and also visited scientific
institutions in Sweden, U.K. and U.S.A. under Training Program on Capacity Building in Environmental
Research Management (World Bank Funding Project). After his superannuation in the year 2011, he has
been associated with International Institute of Herbal Medicine (IIHM), Lucknow, India as Professor and is
presently associated with Sky Institute, Lucknow , India as Director ( Research) and involved in programs
related to higher education and research of scientific & technological fields. He has organized several
3
166 www.ijsir.co.in
International Journal of Scientific and Innovative Research 2013; 1(1) P-ISSN 2347-2189, E- ISSN 2347-4971
national and international conferences. He has actively participated in national and international conferences,
symposia and workshops and presented research papers and chaired scientific / technical sessions. He is
life member and fellow of many scientific societies such as National Academy of Sciences India , Society
of Toxicology of India, Indian Academy of Neurosciences, Bioved Research Society India, International
Society for Herbal Medicine (ISHM), Society of Biological Sciences and Rural Development, India. He has
been member of several scientific expert committees/ advisory committees to evaluate scientific research
proposals. Dr. Pandey has been actively associated with various universities and institutions in India as
examiner for conducting graduate, post graduate and doctoral level examinations in disciplines like chemical
sciences, pharmaceutical sciences, biochemical sciences, biotechnology and allied areas and member of
Board of Studies for the academic development in the department. He has been approved research supervisor
for guiding research in chemistry, biotechnology and related areas from various universities of India leading
to PhD Degree. In view of his vast research and administrative experience and broad R & D vision, Dr.
Pandey has been associated with International Journal of Scientific & Innovative Research (IJSIR) as
Editor-in-Chief.
4
International Journal of Scientific and Innovative Research 2013; 1(1) P-ISSN 2347-2189, E- ISSN 2347-4971
www.ijsir.co.in 167
FROM THE DESK OF CHAIRMAN, SKY INSTITUTE
It is my privilege to state that I have great desire to contribute to the
development of our country and to bring about social transformation through
education, higher learning and research. This inner feeling prompted me to establish
Sky Institute in Lucknow (Uttar Pradesh), the city known for its rich cultural heritage
and vibrant academic institutions of higher learning. Sky Institute, since its inception
in the year 2006, has been functioning to impart various educational and training
courses with a vision to improving lives through education, research and innovation. The institute provides
a professional learning environment that acts as a catalyst, for the exponential growth of student as well as
extracurricular abilities. It conducts regular courses at the level of graduate and post graduate followed by
research courses leading to M Phil and PhD in all subjects in association with universities .
I feel great pleasure to highlight that Sky Institute has started to publish a bi-annual journal
“International Journal of Scientific and Innovative Research ( IJSIR ) which encourages to publish research
articles in all branches of science, technology ,engineering, health, agriculture and management. Research
articles in the field of education are also considered in order to improve educational standard in educational
institutions with innovative technologies. First volume of the journal has been successfully published. The
present issue of second volume of the journal contains useful and informative research articles which
may be interesting to readers and educational and research organizations. The association of eminent
faculty and scientists of reputed organizations with our journal is highly appreciable.
I call upon all the students who are willing to join various programs/courses being run at Sky
Institute in association with selected universities, to strive hard to gain knowledge, transform it into skills
with right attitude and inculcate the habit of learning, which will drive them to self directed learning.
My best wishes to all the aspiring students.
5
Mohit Bajpai
Chairman
Sky Institute
1
International Journal of Scientific and Innovative Research 2013; 1(1):1-13
THERAPEUTIC POTENTIAL OF PICRORRHIZA KURROA IN
PREVENTION AND TREATMENT OF HEPATIC DISORDERS: AN
OVERVIEW
*B.R.PANDEY1,2
, P. VERMA1
1. International Institute of Herbal Medicine (IIHM), Gomti Nagar, Lucknow, U.P., India.
2. Sky Institute for Higher Education &Research, Kursi Road , Lucknow, U.P., India
ABSTRACT
The liver being vulnerable to wide variety of metabolic, toxic, microbial, circulatory and neoplastic insults is
subjected to potential damage resulting in acute or chronic hepatic disorders. Viral hepatitis has always been
a disease of major concern. The existence of atleast five distinct viral hepatitis agents has been documented
namely HAV, HBV, HCV, HDV and HEV. Distinctive differences in symptoms of disease like onset, severity,
prevalence, season, serological markers, clinical course etc lead to distinguish the causative agent. Liver
disorders may be as acute or chronic hepatitis (inflammatory liver disease), hepatosis (non- inflammatory
disorders) and liver cirrhosis (degenerative disorder resulting in fibrosis of the liver). An actual curative
therapeutic agent has not yet been found. In fact most of the available remedies rather support or promote the
process of healing or regeneration of the liver. The drugs available in the modern system of medicine are the
corticosteroids and immunosuppressive agents which bring about only symptomatic relief and in most cases
have no influence on the disease process. Their use is also associated with the risk of relapses and danger of
side effects. In addition, two types of hepatitis B vaccines (plasma derived and recombinant) have also been
developed and are available. These vaccines are too expensive and cannot be afforded by common patients.
These vaccines also produce few side effects. Considering the non availability of effective, safe and cheep
drugs for the cure of hepatic disorders, usefulness of alternate herbal therapy is currently being evaluated by
scientists and clinicians. Picrorrhiza kurroa is one of the most important herbs of ayurveda which forms an
ingredient of many Indian herbal preparations used for the treatment of liver disorders. The alcoholic extract
of Picrrorhiza kurroa has been shown to demonstrate significant hepato protective effect which appeared to
be due to a mixture of two iridoid glycosides (picroside 1 and kutkoside) known as picroliv (kutkin). It has
been found more active than a known hepatoprotective drug silymarin. Considering beneficial action of
Picrorrhiza kurroa in protection of hepatic damage, an organic herbal formulation, Liver-Kidney-Care
consisting of three medicinal herbs namely Picrorrhiza kurroa, Boerhavia diffusa and Phylanthus nirruri has
been developed by International Institute of Herbal Medicine (IIHM), Lucknow, India. This formulation is
free of pesticides, insecticides, weedcides, toxins and harmful chemicals. Liver –Kidney - Care has been
found to provide beneficial effect to patients of hepatic disorders attending the clinic of IIHM and several
patients have been cured with the treatment of this herbal drug. Therefore, this herbal formulation alone can
be used as alternative medicine in the treatment of hepatic disorders or it can also be used as adjunct /
complimentary medicine.
Keywords: Picrorrhiza kurroa, Picroliv, iridoid glycosides, viral hepatitis, hepatoprotective activity,
Liver- kidney- Care.
*Corresponding author- Dr. B.R. Pandey, Director (Research), Sky Institute for Higher Education
& Research, Kursi Road, Lucknow, U.P., India, [email protected]
2
INTRODUCTION
The liver being vulnerable to wide variety of
metabolic, toxic, microbial, circulatory and
neoplastic insults is subjected to potential
damage resulting in acute or chronic hepatic
disorders. Viral hepatitis has always been a
disease of major concern. The existence of at
least five distinct viral hepatitis agents has been
documented namely HAV, HBV, HCV, HDV
and HEV. Distinctive differences in symptoms
of disease like onset, severity, prevalence,
season, serological markers, clinical course etc
lead to distinguish the causative agent.
Hepatitis A is most often contracted through the
fecal-oral route and it is self limiting school
children are at particular risk. Hepatitis B is
usually transmitted by parental inoculation of
virus contacting material and so the others too
have serious complications. The hepatitis B
virus (HBV) is transmitted by horizontal and
vertical routes and causes both acute and
chronic liver diseases which are often
associated with chronic sequelae including the
development of hepatocellular carcinoma
(HCC). An actual curative therapeutic agent has
not yet been found. In fact, most of the
available remedies rather support or promote
the process of healing or regeneration of the
liver. The drugs available in the modern system
of medicine are the corticosteroids and immune
suppressive agents which bring about only
symptomatic relief and in most cases have no
influence on the disease process. Further, their
use is associated with the risk relapses and
danger of side effects. Although, efforts are
being made to develop drugs and vaccines for
effective control of hepatitis, there is need to
explore medicinal plants which are abundantly
available in our country in order to develop
safe, cheap and long acting hepatoprotective
drugs. Extensive work has been carried out on
few medicinal plants namely, Acacia catechu,
Andrographis paniculata, Boerhaavia diffusa,
Citrullus colocynthis, Eclipta alba, phylanthus
niruri, Picrorrhiza kurroa, Piper longum,
Solanum nigrum, Terminalia ariuna, Tinospora
cordifolia, Withania somnifera, Withania
coaqulans, Silymarin, Phyllanthus amarus using
experimental animals. These plants exhibited
significant hepatoprotective activity.The plant
extracts showing promising results in animal
model have been subjected for further screening
against HBV infected human sera using
Enzyme linked Immunosorbant Assay
(ELISA). Amongst above plants, Picrorrhiza
kurroa forms an ingredient of many Indian
herbal preparations used for the treatment of
liver ailments [1-3]
. This review highlights the
major findings of previous studies on
Picrorrhiza kurroa.
Active Constituents
The alcoholic extract of Picrorrhiza kurroa
contains two iridoid glycosides. Picroliv
(Kutkin) and its two major irridoid glycosides
viz. picroside I and kutkoside (Figure 2) have
been isolated and described. Both picroside I
and kutkoside were the cinnamoyl and vanilloyl
esters of catalpol. The latter was prepared by
alkaline hydrolysis of the mixture of picroside I
and kutkoside followed by purification of the
resulting product by chromatography. [4]
Picroliv is a standardized iridoid glycoside
fraction obtained from root and rhizome of the
plant picrorrhiza kurroa.
Many other active constituents have been
identified including nine cucurbitacin
glycosides, apocynin and dorsin. [5]
3
Botanical classification of
Picrorrhiza kurroa :-
Kingdom : Plantae
Order : Angiosperm
Family: Scrophulariaceae
Genus: Picorrhiza
Species: kurroa
4
Hepatoprotective activity
Several research studies have shown that
extracts of Picrorrhiza (P. kurroa) popularly
known in India as “Kutkin” possess marked
protective action on liver. Studies were
conducted to evaluate hepatoprotective activity
of alcoholic extract of P. kurroa and kutkin in
some models of hepatic damage in rodents and
the results showed that the alcoholic extract of
the root and rhizome of P. kurroa exhibited
hepatoprotective activity in rat and mastomys.
The active principle was identified as kutkin
and the kutkin free fraction of the extract were
found to be devoid of any activity. Kutkin
showed significant hepato protective activity in
hepatic damage induced by galactosamine (in
rats) and plasmodium berghei (in mastomys) as
assessed by changes in several serum and liver
biochemical parameters [2, 4]
. Further, studies
have been conducted to see the effect of
picroliv on Plasmodium berghei induced
hepatic damage in mastomys natalensis and the
results showed that administration of picroliv, a
standardized fraction of alcoholic extract of
Picrorrhiza kurroa (3-12 mg/kg/day for two
weeks) simultaneously with P. berghei infection
showed significant protection against hepatic
damage in mastomys natalensis. The increased
levels of serum glutamate oxaloacetate
transminase (GOT), glutamate pyruvate
transminase (GPT), alkaline phospahatase,
lipoprotein X(LP-X) and bilurubin in the
infected animals were markedly reduced by
different doses of picroliv. In the liver, picroliv
decreased the level of lipid peroxides and
hydroperoxides and facilitated the recovery of
superoxide dismutase and glycogen. Picroliv
had no effect on the degree of parasitaemia [6]
.
In another experimental study, the
investigations were carried out on the effect of
oral administration of picroliv, obtained from
total alcohol extractable rhizome of P. kurroa
concurrently with toxication of rats for two
weeks with carbon tetra chloride (CCl4) and the
results showed that administration of carbon
tetra chloride to normal rats increased activities
of hepatic 5’- nucleotidase, acid phospahatase,
acid ribonuclease while the activities of
succinate dehydrogenase, glucose 6-
phosphatse, superoxide dismutase and
cytochrome p450 were decreased. Levels of
lipid peroxides, total lipids and cholesterol of
liver were also increased. The activities of
serum glutamate oxaloacetate transaminase,
glutamate pyruate transminase and alkaline
phosphatase were increased. Other serum
parameters showing changes after CCL4 were
bilirubin, proteins, cholesterol, triglycerides and
lipoprotein –X. Picroliv in doses of 6 and 12
mg / Kg provided a significant protection
against most of the biochemical alterations
produced by the CCL4. The degree of
protection afforded by picroliv, when
administered simultaneously or as a
pretreatment was almost equal [7].
Studies were
conducted to see the protective action of
picroliv on isolated rat hepatocytes against
thioacetamide induced injury and the results
showed that picroliv showed dose – dependent
protective activity on isolated hepatocytes (ex-
vivo) against thioacetamide - induced hepatic
damage in the rat . It enhances the percentage
of viable hepatic cells. Picroliv also
antagonized the changes in the enzymes GOT,
GPT and alkaline phophatase produced by
thio-acetamide both in isolated hepatocyte
suspension as well as in serum.
5
It was found to be more potent than silymarin ,a
known hepatoprotective agent[8]
. Picroliv, the
active principle of P. kurroa and its main
components which are a mixture of the iridoid
glycocides, picrocide 1 and kutkoside were
studied in vitro as potential scavengers of
oxygen free radicals. The superoxide (O2-)
anions generated in a xanthine-xanthine oxidase
system , as measured in terms of uric acid
formed and the reduction of nitroblue
tetrazolium were shown to be suppressed by
picroliv, picroside 1 and kutkoside. Picroliv as
well as both glycosides inhibited the non-
enzymatic generation of O2- anions in
aphenazine methosulphate NADH system.
Malonaldehyde (MDA) generation in rat liver
microsomes as stimulated by ascorbate Fe2+
and
NADPH-ADP-Fe 2+
systems was shown to be
inhibited by the picroliv glycosides. Known
antioxidants tocopherol (Vitamin E) and
butylated hydroxy anisole (BHA) were also
compared with regard to their antioxidant
actions in the above system. It was found that
BHA afforded protection against ascorbate Fe2+
induced MDA formation in microsomes but did
not interfere with enzymatic or non-enzymatic
O2- anion generation and tocoferal inhibited
lipid peroxidation in microsomes by both
peroxidant systems and the generation of O2-
anions in the non enzymatic system but did not
find interfere with xanthine oxidase activity.
This study shows that picroliv, picroside-1 and
kutkoside possess the properties of antioxidants
which appear to be mediated through activity
like that of superoxide dismutase, metal ion-
chelators and xanthine oxidase inhibitors. These
results suggested that the hepatoprotective
action of picroliv glycosides may be due to the
prevention of lipid peroxidation and free radical
generation during liver damage [9]
.
Effect of Picroliv, the active principle from
Picrorrhiza kurroa, on glutathione metabolism
in liver and brain of Mastomys natalensis
infected with plasmodium berghei was studied
and it was found that administration of Picroliv
at a dose of 6mg/kg, po for two weeks showed
significant protection against changes in liver
and brain glutathione metabolism of
plasmodium berghei infected Mastomys
natalensis. The depletion of reduced
glutathione level and inhibition of glutathione-
s-transferase, glutathione reductase and
glutathione peroxidase activities due to P.
berghei infection were markedly reduced by
picroliv. The increased levels of lipid
peroxidation products in damaged tissue were
also reduced along with recovery of
glutathione metabolism [10]
.
Studeis were also conducted to see the effect
of picroliv on γ-glutamyl cycle in liver and
brain of Mastomys natalensis infected with
Plasmodium berghei and it was observed that
the activation of γ -glutamyl transpeptidase
enzyme and decreased levels of cystine,
sulphydryl groups as well as glutathione
synthesis in both tissues due to P. berghei
infection were reversed by picroliv. Enzymatic
and non – enzymatic lipid peroxidation in
microsomes in vitro was significantly reduced
by Picroliv along with recovery of reduced
glutathione [11]
. The effect of Picroliv was
investigated on oxidative modifications of
serum lipoproteins in Plasmodium berghei
infected Mastomys coucha and the results of
the study showed that picroliv at the dose of
6mg/kg po for two weeks provided significant
protection against the generation of lipid
peroxidation products in serum ᵦ- lipoproteins
of Plasmodium berghei infected M. coucha.
Incubation of normal rat hepatocytes with very
low density lipoproteins
6
or low density lipoprotein isolated from
infected animals caused significant
generation of lipid peroxides followed by a
decrease in the viability of these cells,
however, these effects were partially reversed
with lipoproteins from infected and picroliv
treated groups. High density lipoprotein from
infected animals was not toxic to hepatocytes
in vitro [12]
. Picroliv (active principle from P.
kurroa), its major components picroside 1,
catapol, kutkoside 1, kutkoside were tested for
the presence of anti hepatitis B virus surface
antigen (anti HBs) like activity, HBs Ag.
Positive serum samples obtained from
hepatitis B virus (HBV) associated acute and
chronic liver diseases and healthy HBs ag
carriers were used to evaluate the anti HBs
like activity of compounds / extract. The latter
were mixed with serum sample and incubated
at 37oC
overnight followed by HBs Ag
screening in the ELISA system. A promising
anti- HBs Ag like activity was noted in
Picroliv (and its major components) catalpol
which differed from the classical
neutralization. Picroliv also inhibited purified
HBV antigens prepared from healthy HBsAg
carriers [2,13]
. Picroliv has been shown to
possess dose dependent (0.75-12 mg/kg x 7
days) protective activity on isolated
hepatocytes (ex-vivo) against paracetamol-
induced hepatic damage in rats. It increased
the percentage viability of the hepatocytes.
Picroliv also restored the normal values of
enzyme (glutamic oxaloacetic transminase
[GOT], glutamic pyruvic transminase [GPT]
and alkaline phophatase) both in isolated
hepatocyte suspension as well as in the serum.
Picroliv was found to be more potent than
silymarin , a known hepatoprotective agent [14,
15].
In another study, picroliv has been shown to
exhibit a significant dose dependent (3-
12mg/kg po x 7 days ) protective activity
against galactosamine induced hepatic
damage in rats as evaluated on the isolated
hepatocytes (ex. vivo) prepration. It markedly
increased the percentage of viability of
hepatocytes. It was also found to restore the
galactosamine- induced changes in the levels
of enzymes (GOT; GPT and alkaline
phosphatase) both in isolated hepatic cells as
well as in serum. Picroliv was also found to
possess a marked anticholestatic effect.
Picroliv was found to be more potent than
silymarin, a standard hepatoprotective agent [16]
.
Picroliv has also been found to possess a
dose (3-12 mg/kg, po for 7 days) dependent
choleretic activity as evidenced by increase in
bile flow and its contents (bile salts and bile
acids). Significant anticholestatic activity was
also observed against carbon tetrachloride
induced cholestasis in conscious rat,
anaesthetized guinea pig and cat. Picroliv
was found to be more active than the known
hepatoprotective drug silymarin [17]
. An
experimental study was conducted to
evaluate hepatoprotective effect of Picroliv
against Rifamicine-induced toxicity in
animals. The results of the study showed that
Picroliv exhibited significant
hepatoprotective as well as an anticholestatic
activity against rifamicine-induced hepatic
damage. Rifamicine (50 mg/kg ipx6 days)
resulted in the reduction of bile flow as well
as its contents (bile salt and bile acids) in the
conscious rat and anesthelized gunea pig.
Further, it also caused a decrease in the
viability and rate of oxygen consumption in
7
isolated rat hepatocytes. Picroliv treatment
significantly reversed the altered parameter of
bile and hepatocytes. Picroliv was found to be
more active than known hepatoprotective drug
silymarin. The modulation of rifamicin toxicity
by picroliv indicated that this agent could be
given simultaneously to tuberculosis patients
to protect the liver from rifamicine induced
toxicity[18-19]
. Considering the beneficial action
of Picrorrhiza kurroa in protection of hepatic
damage, International Institute of Herbal
Medicine (IIHM), Lucknow, India, has
developed an organic herbal formulation,
“Liver – Kidney - Care” consisting of
Bhumiamalaki- Phyllanthus niruri, 125 mg,
Punarnava- Boerhavia diffusa, 100 mg and
Katuki- Picrorrhiza kurroa, 100 mg. The above
herbal combination at dose of one capsule
twice daily within meals given to patients of
hepatic disease attending the clinic of IIHM
produced beneficial effect to patients. This
above herbal combination are well known for
its hepato-protective effects singly or in
combination with the best ever known hepato-
protective effects proved scientifically[20-21]
.
Liver-Kidney-Care herbal formulation is free
from pesticides, insecticides, weedicide and
herbicides. This herbal formulation alone can
be used as alternative medicine in the treatment
of hepatic disorders or it can also be used as
adjunct/complimentary medicine.
DISCUSSION
In the present days of environmental
degradation, uncontrolled environmental stress,
changing life style and expanding therapy with
the potent drugs, the liver main organ of the
human is continuously exposed to varieties of
xenobiotics and therapeutic agents which
interfere with the various functions of liver
such as metabolic function, detoxicating
function, secretory function and excretory
function leading to liver disorders of varied
nature including acute or chronic hepatitis
(inflammatory liver disease), hepatosis (non-
inflammatory disorders) and liver cirrhosis
(degenerative disorder resulting in fibrosis of
liver). The types of hepatitis may be virus
induced hepatitis, drug/toxin induced
hepatitis, and alcohol induced hepatitis and
autoimmune hepatitis. Viral hepatitis, which
is caused by at least five different and
completely unrelated human pathogens
known as hepatitis A,B, C, D, and E viruses (
HAV, HBV, HCV, HDV and HEV), is of
major concern since the essential lesion is an
acute inflammation of entire liver and hepatic
cell necrosis is associated with leucocytic
reaction and infiltration. Thus, Hepatitis B
virus infection can lead to cirrhosis, acute
liver failure and liver cancer. There are about
45 million people in India carrying the
Hepatitis B virus.
In spite of extensive studies carried out to
develop therapeutic agents using diagnostic
tests / enzyme assays and biomarkers, an
actual curative therapeutic agent for hepatic
disorders has not been found.
In fact, most of the available remedies rather
support or promote the process of healing or
regeneration of liver. The drugs available in
8
modern system of medicine such as
immunoglobulin, ribavirin, lamivudine,
famciclovir, fialuridine, vidarabine,
interferon-alpha.are the corticosteroid and
immunosuppressive agents which may bring
only symptomatic relief and in most cases
have no influence on the disease process.
Further, the use of above drugs is associated
with the risk by relapses and danger of
unwanted side effects/ adverse drug reactions.
In addition, two types of hepatitis B vaccines
(plasma derived and recombinant) have also
been developed and are available. These
vaccines are very expensive and have few side
effects too.
Considering the non availability of effective,
safe and cheep drugs for the cure of hepatic
disorders, usefulness of alternate herbal
therapy is currently being evaluated by
scientists and clinicians throughout the world.
Extensive work has been carried out on few
medicinal plants namely, Acacia catechu,
Andrographis paniculata, Boerhaavia diffusa,
Citrullus colocynthis, Eclipta alba, phylenthus
nirruri, Picrorrhiza kurrooa, Piper longum,
Solanum nigrum, Terminalia ariuna,
Tinospora cordifolia, Withania somnifera,
Withania coaqulans, Silymarin, Phyllanthus
amarus using experimental animals. These
plants have exhibited significant
hepatoprotective activity. The plant extracts
showing promising results in animal model
have been subjected for further screening
against HBV infected human sera using
Enzyme linked Immunosorbant Assay (
ELISA). Picrorrhiza kurroa is one of the most
important herbs of Ayurveda (the traditional
system of medicine in India) which forms an
ingredient of many Indian herbal preparations
used for the
treatment of liver ailments [1]
.
The results of the studies described above
demonstrate that Picrorrhiza kurroa is
effective in prevention and treatment of
hepatic disorders. The presence of two major
iridoid glycosides picroside I and Kutkoside
in alcoholic extract of roots named as kutkin
(picroliv), the active constituent of the plant
Picrorrhiza kurroa has been found to be
responsible in exhibiting hepato protective
actively. Picroliv has been found to be more
active than the known hepato-protective drug
silymarin. It has been hypothesized that the
hepato protective activily of this drug may be
based on (1) Kutkins alter the structure of the
outer membrane of the hepatocytes in such a
way as to prevent penetration of the liver
toxin into the interior of the cell, (2) Kutkins
stimulate the action of nucleolar polymerase
A, resulting in ribosomal protein synthesis
and, thus stimulates the regenerative ability
of the liver and formation of new
hepatocytes, (3) Apocynin, is one of its
constituents, has been found to exhibit
powerful anti-inflammatory effects on a
variety of inflammatory models[22]
. Further,
few studies conducted on experimental
models have shown that the therapeutic
actively of the plant towards hepatic
damage/injury might be due to its antioxidant
and cholerectic activity. Like silymarin,
Picrorhiza does possess significant
antioxidant activity in vitro which may
contribute to the hepatoprotective effect by
reducing lipid peroxidation and free radical
damage [9]
.
Chander et al found that Picrorrhiza and
its main constituents, picroside-I and
kutkoside, inhibited the nonenzymatic
generation of
9
O2-anions in a phenazine methosulphate
NADH system, inhibited oxidative
malonaldehyde generation by both the
ascorbate-Fe2+ and NADPH-ADP-Fe2+
systems, and scavenged superoxide (O2-)
anions generated in a xanthine-xanthine
oxidase system. In other words, Picrorrhiza
demonstrated antioxidant activity similar to
that of superoxide dismutase, metal-ion
chelators, and xanthine oxidase inhibitors [9]
.
Glutathione is vital to maintaining a variety of
intracellular functions, including
detoxification, antioxidation, tertiary protein
configuration, and redox balance [23]
.
Picrorrhiza was found to restore depleted
glutathione levels in African desert rats
infected with Plasmodium berghei (malaria).
Several enzymes associated with glutathione
function were also restored, including
glutathione-S-transferase, glutathione
reductase, and glutathione peroxidase [10]
.
Generation of lipid peroxides in African
desert rats infected with Plasmodium berghei
was significantly reduced by Picrorhiza at the
oral dose of 6 mg/kg for two weeks, revealing
Picrorrhiza also possesses anti-lipid
peroxidative effects [11]
. The hepatoprotective
action of Picrorrhiza kurroa may be due to its
ability to stimulate liver regeneration. Like
silymarin, Picrorrhiza may have an effect on
liver regeneration. A 1992 study demonstrated
stimulation of nucleic acid and protein
synthesis in rat liver with oral administration
of Picrorhiza. The authors stated the results
were comparable to silymarin [24]
.
Another factor in the hepatoprotection of
Picrorrhiza may be its anti-inflammatory
effects. Picrorrhiza extracts were found to
have an inhibitory effect on such pro-
inflammatory cells as neutrophils,
macrophages, and mast cells. [25]
The authors
suggested Picrorrhiza extract inhibited
membrane mediated activation of these cells
(inhibited 8-adrenergic receptors).[26-27]
The
researchers found no effect of the Picrorrhiza
extract on prostaglandin production. [25]
Picrorrhiza contains apocynin, a catechol, as
one of its minor constituents. Apocynin has
been found to exhibit powerful anti-
inflammatory effects on a variety of
inflammatory models. Apocynin was found
to inhibit neutrophil oxidative burst in vitro
without affecting beneficial activities such as
chemotaxis, phagocytosis, and intracellular
killing of bacteria [28-29]
. In vivo animal
models, apocynin inhibited
lipopolysaccharide-induced emphysema in
hamsters. [30]
Apocynin prevented the formation of
ulcerative lesions in rats injected
intracutaneously with Freund’s complete
adjuvant. [31]
10
and reduced swelling in collagen-immunized
rats. No effects on humoral and cellular
immunity were observed after treatment with
apocynin. [32-33]
Interestingly, the effective
daily dose of apocynin was only 0.024 mg/
kg. Such a dose is readily achieved from
normal use of Picrorrhiza root instead of the
concentrated apocynin extract [32-33]
. Several
hepatotoxins, including paracetamol and
ethynylestradiol, have a cholestatic effect on
the production of bile. Picrorrhiza has been
shown to reverse acetaminophen and
ethynylestradiol-induced cholestasis,
maintaining both bile volume and flow.
Silymarin was tested simultaneously for
comparison. Picrorrhiza was found to be a
more potent choleretic and anticholestatic
agent than silymarin.[34]
As for as
dosage/toxicity is concerned, picrorrhiza is
poorly soluble in water and so is usually not
taken as a tea. It is soluble in ethanol and so
can be taken in tincture form (very bitter), but
is usually administered as an encapsulated
standardized extract (4% kutkin) [35]
. The
usual adult dosage is 400 to 1500 mg/day,
although daily doses as high as 3.5 g/ day
have been recommended for fevers [36]
.
Picrorrhiza use is widespread in India and no
major adverse reactions have been reported.
The oral LD50 of kutkin is greater than 2600
mg/kg in rats [37]
.
The LD50 of picrocide and kutkoside is
greater than 1000 mg/kg in rats [37]
. By
comparison, the maximum dose achievable
with oral ingestion of picrorrhiza root is
about 3-6 mg/kg. Considering beneficial
action of Picrorrhiza kurroa in protection of
hepatic damage/injury, an organic herbal
formulation, Liver-Kidney-Care consisting of
three medicinal herbs namely Picrorrhiza
kurroa, Boerhavia diffusa and Phylanthus
nirruri has been developed by International
Institute of Herbal Medicine (IIHM),
Lucknow, U.P., India. This formulation is
free from pesticides, insecticides, weedcides
toxins and harmful chemicals. Liver –Kidney
-Care has been found to provide beneficial
effect to patients of hepatic disorders
attending the clinic IIHM and several patients
have been cured with the treatment of this
herbal formulation. As evidenced from
encouraging results of this herbal formulation
in treatment of patients with hepatic
disorders, it can be recommended for the
cases of fatty or sluggish liver, viral hepatitis,
cirrohosis, hepatic enlargement, kidney
stones, pyelonephritis, renal failure and
urinary tract infection. It has capability to
regulate fat metabolism in obesity and to
improve appetite during convalescences. This
herbal formulation has potential to eliminate
hepato toxic agents such as alcohol, chemical
pollutant and drugs from the complex human
system. Therefore, this herbal formulation
alone can be used as alternative medicine in
the treatment of hepatic disorders or it can
also be used as adjunct / complimentary
medicine. As a preventive treatment 1-2
capsules of Liver-Kidney-Care daily can be
taken for any length of time without side
effects.
11
Although beneficial results have been
obtained with the treatment of Liver-Kidney-
Care at dosage of 1-2 capsule twice a day
within meal for at least one month to the
patients, multidisciplinary clinical studies in
human subjects using modern
biotechnological tools and biomarkers may
prove to be useful in understanding the
biochemical mechanism of action of organic
herbal formulation “Liver-Kidney-Care”
containing hepatoprotective herb Picrorrhiza
kurroa in prevention and treatment of hepatic
disorders.
ACKNOWLEDGEMENTS
The authors are thankful to Dr. Narendra
Singh, Director, International Institute of
Herbal Medicine (IIHM), Lucknow, UP,
India, who expired on July 31st 2012 due to
his serious illness and detoriating health
condition, for providing clinical detail and
study protocols in treatment of patients of
hepatic disorders attending the clinic of
IIHM, Lucknow.
REFERENCES
1. Honda SS, Sharma A, Chakraborti KK. Natural
products and plants as liver protecting drugs.
Fitoterapia 1986; 57: 307-351.
2. Vaidya AB, Antarkar DS, Doshi JC, Bhatt
AD, Ramesh V, Vora PV, Perissond D, Baxi
AJ, Kale PM. Picrorhiza kurroa (Kutaki) Royle
ex Benth as a hepatoprotective agent--
experimental & clinical studies. J Postgrad
Med. 1996; 42(4):105-108.
3. Ram VJ. Herbal preparations as a source of
hepatoprotective agents. Drug News
Perspect. 2001;14(6):353-363
4. Ansari RA, Aswal BS, Chander R, Dhawan
BN, Garg NK, Kapoor NK, Kulshrestra DK,
Mehdi H, Mehrotra BN, Patnaik GK and
Sharma SK. Hepatoprotective activity of kutkin
the iridoid glycoside mixture of Picrorrhiza
kurroa. Indian J Med Res. 1988; 87:401-404.
5. Stuppner H, Wagner H. New cucrbitacin
glycosides from Picrrhiza kurroa. Planta Med.
1989;55:559-563.
6. Chander R, Diwedi Y, Rastogi R, Sharma SK,
Garg NK, Kapoor NK and Dhawan BN.
Evaluation of Hepatoprotective activity of
Picrolive in Mastomys Matalensis infected with
Plasmodium Berghei. Ind J Med Res. [B],
1990; 92: 34-37.
7. Diwedi Y, Rastogi Ram, Chandra Ramesh,
Sharma SK, Kapoor NK, Garg NK, dhawan
BN. Hepatoprotective activity of Picrolive
against Carbon tetrachloride induced liver
damage in rats. Ind J Med Res. [B], 1990;
92:195-200.
8. Visen PKS, Shukla B, Patnaik GK, Chanda R,
Singh V, Kapoor NK, Dhawan BN.
Hepatoprotective activity of Picrolive isolated
from Picrorrhiza kurroa against Thioacetamide
toxicity on Rat Hepatocytes. Phytotherapy
Researc. 1991; 5: 224-227.
9. Chander R, Kapoor NK, Dhawan BN,
Picrolive, Picroside-1 and Kutkoside from
Picrorrhiza kurroa an scavenger of super oxide
anion. Biochemical pharmacology. 1992; 44(1):
180-183.
10. Chander R, Kapoor NK, Dhawan BN. Effect
of Picroliv on Glutathione Metabolism in
Liver and Brain of Mastomys Natalensis
Injected with Plasmodium Berghei. Indian J Exp
Biol. 1992; 30: 711- 714.
12
11. Chander R, Kapoor NK, Dhawan
BN. Picroliv affects Gamma-Glutamyl Cycle
of Liver And Brain of Mastomys Infected with
Plasmodium Berghei. Indian J Exp Biol. 1994; 32:
324-327.
12. Chandra R, Singh K, Visen PKS, Kapoor NK,
Dhawan BN. Picroliv Prevents oxidation in serum
lipoprotein lipids of Mastomys concha infected with
Plasmodium berghei. Ind J of Exp Biol. 1998; 36:
371-374.
13. Mehrotra R, Rawat S, Kulshreshtha DK, Patnaik GK,
Dhawan BN. In Vitro Studies on Effect of Certain
Natural Products against Hepatitis B Virus. Indian J
Med Res. 1990; 92:133-138.
14. Visen PKS, Shukla B, Patnaik GK,
Kaul, Surabhi, Kapoor NK,
Dhawan BN. Hepatoprotective Activity of Picroliv,
The Active Principle of Picrorhiza Kurroa on Rat
Hepatocytes against Paracetamol
Toxicity. Drug Dev Res. 1991; 22: 209-219.
15. Verma PC, Basu V, Gupta V, Saxena G, Rahman LU.
Pharmacology and chemistry of a potent
hepatoprotective compound Picroliv isolated from the
roots and rhizomes of Picrorhiza kurroa royle ex
benth. (kutki). Curr Pharm
Biotechnol. 2009;10(6):641-649.
16. Visen Pks, Shula B, Patnaik GK,
Dhawan BN. Prevention ofGalactosamine Induced
Hepatic Damage byPicroliv.Study on bile flow and
isolated hepatocytes (Ex-Vivo). Planta Med. 1993; 59:
37-41.
17. Saraswat B, Visen PKS, Patnaik
GK, Dhawan BN. Anticholestatic effect of Picroliv,
active hepatoprotective
principle of Picrorhiza Kurroa, against Carbon
Tetrachloride Induced Cholestasis. Indian J Exp Biol.
1993; 31: 316-318.
18. Saraswat B, Visen PKS, Patnaik GKand Dhawan BN.
Hepatoprotective effect of Picroliv against Rifamcin
induced toxicity. Drug development research. 1997;
40: 299-303.
19. Jeyakumar R, Rajesh R, Meena B, Rajaprabhu D,
Ganesan B, Buddhan S, Anandan R. Antihepatotoxic
effect of Picrorhiza kurroaon mitochondrial defense
system in antitubercular drugs (isoniazid and
rifampicin)-induced hepatitis in rats. Journal of
Medicinal Plants Research. 2008; 2 (1):17–19.
20. Chaturvedi S, Singh N, Abbas SS. Effect of
'Liver-Kidney Care' an Ayurvedic Formulation in
Cases of Various Liver and Kidney Disorders.
2nd World Congress on Biotechnological
Developments of Herbal Medicine, February 20-
22, 2003, Luknow India.
21. Singh N, Abbas SS, Bhalla M, Verma VK. Clinical
evaluation of Organic Liver Kidney Care
formulation in some cases of hepatitis B,
Processings of Workshop on “Essential Medicines,
Adverse Drug Reactions & Therapeutic Drug
Monitoring”, pp.145, organized by King George’s
Medical University, Lucknow, India, 22nd-23rd
August, 2005.
22. Singh AP. Kutkins: A Review of Chemistry and
Pharmacology. Ethnobotanical leaflets. An
international Journal of Ethnobotanical Research.
2005:1, Article 26.
23. Kidd PM. Glutathione: Systemic protection against
oxidative and free radical damage. Altern Med Rev
1997;2:155-176.
24. Singh V, Kapoor NK, Dhawan BN. Effect of
picroliv on protein and nucleic acid synthesis. Indian
J Exp Biol. 1992; 30:68-69.
25. Pandey BL, Das PK. Immunopharmacological
studies on Picrorhiza kurroa Royle-ex-Benth. Part
IV: Cellular mechanisms of anti-inflammatory
action. Indian J Physiol Pharmacol. 1989; 33:28-30.
26. Pandey BL, Das PK. Immunopharmacological
studies on Picrorhiza kurroa Royle-Ex-Benth. Part
V: Anti-inflammatory action: relation with cell types
involved in inflammation. Indian J Physiol
Pharmacol 1988; 32:289-292.
27. Pandey BL, Das PK. Immunopharmacological
studies on Picrorhiza kurroa Royle-ex-Benth. Part
III: Adrenergic mechanisms of anti-inflammatory
action. Indian J Physiol Pharmacol 1988;32:120-
125.
28. Simons JM,‘t Hart BA, Ip Vai Ching TR, et al.
Metabolic activation of natural phenols into
selective oxidative burst agonists by activated
human neutrophils. Free Radic Biol Med 1990;
8:251-258.
29. Stolk J, Hiltermann TJ, Dijkman JH, Verhoeven AJ.
Characteristics of the inhibition of NADPH oxidase
activation in neutrophils by apocynin, a methoxy-
substituted catechol. Am J Respir Cell Mol Biol
1994;11:95-102.
30. Stolk I, Rossie W, Dijkman JH. Apocynin improves
the efficacy of secretory leukocyte protease inhibitor
in experimental emphysema. Am J Respir Crit Care
Med 1994;150:1628- 1631.
31. ‘t Hart BA, Elferink IG, Nibbering PH. Effect of
apocynin on the induction of ulcerative lesions in rat
skin injected with tubercle bacteria. Int J
Immunopharmacol 1992;14:953-961.
13
32. ‘t Hart BA, Bakker NP, Labadie RP, et al. The
newly developed neutrophil oxidative burst
antagonist apocynin inhibits joint-swelling in
rat collagen arthritis. Agents Actions Suppl
1991; 32:179-184.
33.‘t Hart BA, Simons IM, Knaan-Shanzer S, et al.
Antiarthritic activity of the newly developed
neutrophil oxidative burst antagonist apocynin.
Free Radic Biol Med. 1990 ; 9:127- 131.
34.Shukla B, Visen PK, Patnaik GK, et al.
Choleretic effect of picroliv, the
hepatoprotective principle of Picrorhiza
kurroa. Planta Med 1991;57:29-33.
35.Chopra RN. Indiginous Drugs of India. 2nd
ed.
Reprint. Calcutta, New Delhi: Academic
Publishers; 1982.
36. Kapoor LD. CRC Handbook on Ayurvedic
Medicinal Plants. Boca Raton, Florida: CRC
Press;1990).
37.Annual Report, Regional Research Laboratory,
Council for Scientific and Industrial Research,
India. 1989-1990.
14
International Journal of Scientific and Innovative Research 2013; 1(1):14-17
MEDICAL TOURISM DRIVING THE GROWTH OF THE INDIAN HEALTH CARE SYSTEM
*Bharat Shah Sanjay Gandhi Post Gratuate Institute of Medical Sciences U.P ,Lucknow, India
*Research Scholor, Sai Nath University, Ranchi, India
ABSTRACT
India has an additional requirement of 0.8 million doctors and 1.7 million nurses, apart from facing a significant shortage of paramedics. 45% of the population travels more than 100 Kms to access tertiary level of medical care. Poor accessibility, accountability, affordability, and availability of healthcare services are key constraints that make the idea of ‘Health for all’ a seemingly impossible accomplishment. Besides, the sector is largely dominated by unorganized private players, mostly comprising of clinics and nursing homes. These facilities offer limited range of services and operate with minimal standards of quality. Moreover, the public sector focus is mainly on primary care with a program based approach. Other issues restricting growth of the sector are of high capital expenditure, high dependence on imported medical equipments, long gestation period for the business to turn profitable, archaic norms for medical education, and absence of any central governing authority for paramedical education.
INTRODUCTION
The proper growth of Indian Medical Health Care System and related issues call for an integrated effort and investment across the entire value-chain of healthcare spectrum. Three broad components of this spectrum are healthcare delivery, pharmaceuticals, and medical equipments. Healthcare delivery comprising of primary, secondary and tertiary care facilities, constitutes a major chunk i.e. 77% of the total market. Pharma and medical equipment segments constitute 14% and 5% of the total market, respectively. While sustained expansion of healthcare delivery facilities like neighborhood clinics, day-care surgery
centers, single and multi-specialty hospitals etc. is expected, it is also vital that support sectors and sub-sectors like pharma retail, wellness, medical technology, medical tourism, medical education and health insurance grow alongside and with equal vigor. Though, the role of private sector is going to get extremely crucial, government’s contribution towards achievement of above mentioned expected growth in the healthcare sector cannot be undermined. The government’s focus on healthcare has seen a positive upswing in the last few years and this momentum is likely to sustain in the coming decade with the implementation of a slew of measures proposed by the government.
15
Work is already underway in the setting-up of six world-class institutes of medical education, training and healthcare delivery along the lines of All India Institute of Medical Sciences (AIIMS), Delhi. Also, a total of nine under-graduate and post-graduate medical colleges and hospitals are being established by the Employee State Insurance Corporation (ESIC) not only in metros, but many tier-2 and 3 towns of the country. These two measures will greatly improve accessibility and affordability of healthcare services in non-metro cities, apart from providing quality medical education to many doctors and paramedical professionals.
The Research Methodology includes following steps: DATA COLLECTION
Primary data give original information for specific purposes. It may be collected through survey.
Secondary data consist of information that already exists. The sources of secondary information are news papers, journals, books, magazines and medical Journals. These will be used to get a basic understanding of medical tourism in order to frame relevant questions. The data will be analyzed using correlation analysis. Step 2: Sampling Techniques and Instruments For sampling, the deliberate and stratified techniques shall be used. Questionnaire, Personal Structured Interview, Telephonic Interviews, Internet Feedback will be used as instruments to collects information. ORIGIN OF MTI The revolution in the Indian tertiary (specialized) health care sector took place about 10-15 years ago. Medical tourism originated in India mostly for local expatriates and referred patients. 80% of the interviewees reported that the majority of the medical tourists belong
to the catchment areas of India, namely Middle Eastern countries, SAARC nations (Afghanistan, Nepal, and Sri Lanka), CIS countries and Africa (Nigeria, Congo, Uganda, Tanzania and Namibia). The medical tourists vary from neonates‘to 14 years in the paediatric age group to 90 years for adults. They seek treatment for procedures such as joint replacement (knee), cosmetic reconstructions, dental procedures, cardiology, oncology, gender reassignment, neurology, minimal access bariatric surgery and alternative therapies such as yoga and Ayurveda. India is a preferred medical tourism destination amongst the patients due to the comparatively low cost of treatment; highly skilled medical and paramedical staff trained in the UK and the USA; and superior medical technology. The host hospitals with national and international accreditation promote medical tourism by means of country-specific marketing strategies, seminars, websites, educating the patients about their positive clinical outcomes, medical tourism facilitators and word of mouth recommendation.
The availability of economic and efficient human resources in India, political stability and accreditation of the multi-specialty hospitals (JCI and NABH) are some of the other growth drivers. India, at present, has 200 hospitals offering specialized tertiary care as against 15-20 in Singapore. Fortis Hospital (500 beds) and the recent Medanta Medicity (2000 beds) near the Delhi airport belt offers huge source of foreign exchange earnings from medical tourists.
Effect of globalization on healthcare policies and revenue with regard to Medical Tourism Industry in India
The globalization of healthcare services after signing of the GATS agreement (Mode 2 with cross-border flow of patients) led to the opening up of the Indian economy to the inflow of superior medical equipment, implants, and pharmaceuticals from overseas and improvement in quality standards with the establishment of the competitive benchmarking system and clinical governance.
16
It has led to a transformation of medicine from a country-specific domain to a multinational delivery of healthcare with multiple private hospitals emerging on the global stage such as Medanta Medicity, Fortis, Apollo and Max Healthcare. Globalization has also enabled the expansion of hospital networks overseas, such as Apollo Hospitals in Yemen, Fiji, Mauritius and
Middle Eastern countries. It has also led to the sharing of best clinical practices.
The MDA policy bolsters the wellness sector and incentivizes the hospitals participating in medical tourism as reported by 40% of the interviewees. The Indian National Health Policy of 2002 for promoting medical tourism is better suited for primary and secondary healthcare than tertiary. The foreign exchange earned is invested in medical research and in offering subsidized treatment to the underprivileged.
OPPORTUNITIES OF MTI
With increasing patient awareness and marketing strategies, the trend has reversed from a patient accustomed to being treated by an Indian doctor in his own country to the consumer (medical tourist) following the provider to India. MTI has established niche markets‘ with different countries specializing in certain procedures such as orthopedic and cardiology procedures in India (Macready 2007).
In succinct, as reported by 100% of the interviewees, MTI offers affordable, qualitative, diverse medical care by skilled personnel; an increase in foreign exchange and revenue for host country; mushrooming job opportunities for hospitals, tourism industry and insurance companies; augments the global standing of the developing country; encourages greater investment in the health care infrastructure of the host country and simultaneously promotes a reverse ‗brain drain‘ (migration from developed to developing countries) of medical staff. (Appadurai, 1990; Weisbrot et al., 2000; Cornia, 2001; Dollar et al., 2002; Sharpley, 2003; Fried and Harris, 2007; Horowitz, 2007; Turner, 2007).
It ameliorates the state of overburdened health systems of industrialized nations like USA with 46.6 million people uninsured and helps to combat the long waiting lists for surgeries for UK patients (Starr Sered and Fernandopulle, 2005; Aston, 2006; Milstein and Smith, 2006a; Horowitz, 2007). Simultaneously, it provides opportunities for: cosmetic surgeries; procurement of rare drugs and procedures restricted in developed nations; privacy for patients undergoing fertility treatment; and drug rehabilitation along with an added excursion to the host destination (Batson and Oster, 2007; Breen 2007).
The medical tourism sector has been comparatively recession-free in India (60% of respondents). Additionally, with President Obama‘s healthcare reform in USA, India offers ample opportunities in the medical tourism sector as it offers cheaper treatment. The corporate offices (such as Blue Ridge Paper Products Inc, USA) are also offering packages with India as a medical tourism destination to its employees to cut costs. Additionally, with the increasing geriatric (elderly) in USA and UK there is a greater demand for health care services than can be delivered.
The Indian hospitals such as Apollo, Max, Fortis and Medanta have made agreements with insurance sector (TPAs) to cover post-operative complications for medical tourists such as BUPA, Aetna, Kaiser, Blue Cross and Blue Shield. There is an observed shift in economics from a zone of un-affordability to a zone of affordability of healthcare services such as medical tourists from Nigeria. Another factor is the indirect effect of hosting the Commonwealth Games in Delhi, 2010 where there has been an improvement in the infrastructure of the multi-specialty hospitals with an increase in bed numbers to accommodate the potential rise in foreign patients (medical tourists). McKinsey, US management consultancy, forecasts that Indian MTI will grow to $2 billion per annum by 2012.
CHALLENGES OF MTI
The major challenges of globalization of healthcare services with regard to MTI have been in the
17
area of public sector health inequity due to the private hospitals catering to medical tourists causing a “brain drain” from public to private hospitals. On one hand, some authors such as Bookman (2007) believe that it leads to greater access and quality of healthcare services. On the other hand, 40% of the interviewees and few researchers argue that it leads to unequal work-force distribution (Lipson, 2001; Gawanade, 2003; Sengupta and Nundy, 2005; Wibulpolprasert et al. 2004; Herrick, 2007; Kapur, 2007).
Secondly, there is concern over ethical issues associated with procedures like organ transplantation and reproductive tourism for medical tourists. 60% of the interview respondents either refuse to comment on these parameters, deny any such claim or give inconclusive answers. In addition, due to multiple hospitals offering facilities for medical tourists, there is greater competition amongst them both within them both within India and with countries such as Singapore and Thailand. The quality of care offered under such circumstances is questionable (40% of the interviewees).
Next, the medical tourists are also wary of fraudulent medical tourism facilitators and the occurrence of post-operative complications after departure from India. Hospitals reported difficulty in attracting medical tourists from publicly run healthcare systems such as in USA, UK and Canada due to: the logistics of long distance travel; negative image of India with regard to hygiene and security; four hour travel limit imposed by the UK government for its citizens; opening up of the European Union for UK patients and high customer service expectation as reported by Mudur (2004b), Macready (2007) and 60% of the interviewees. Besides, there are security implications for the treatment of patients from Pakistan. Though the cost of treatment offered for medical tourists in India is reasonable, the hospitals contend that there is a gradual surge in the cost of treatment due to rising import costs of medical equipments and implants being imported. But, the payment potential of the medical tourists (Nigeria) is not increasing at the same rate.
REFERENCE
1. Badara S, Evans T, Dybul M, Atun R, Moatti JP, Nishtar S, Wright A, Celletti F, Hsu J, Kim JY, Brugha R, Russell S. Etienne C: An assessment of interactions between global health initiatives and country health systems. Lancet. 2009; 373:2137-2169.
2. Batson A, Oster S. Change of Heart: China Reconsiders Fairness of 'Transplant Tourism'. Foreigners Pay More for Scarce Organs- Israelis Debate Reform. Wall Street Journal, April 6, Ai. (2007).
3. Blyth E, Farrand A. Reproductive Tourism: A Price worth Paying for Reproductive Autonomy? Critical Soc. Pol‘Y, 25, 91-96. (2005).
4. Kidder L, Judd CM. Research Methods in Social Relations. New York: Holt, Rinehart and Winston. (1986)
5. Koncept Analytics. Medical Tourism Market in Asia: Focus on Thailand, Malaysia, Singapore and India. Availablefrom: <http://www.researchandmarkets.com/reportinfo.asp?report_id=60241> (2008).
6. Kuan Yew, L. (2006). Excerpts from speech by Minister Mentor Mr. Lee Kuan Yew at the SGH 185th anniversary dinner on 16 April 2006 at Ritz-Carlton Millennia. Singapore Medical Association News, 38, 12–15.
7. Sengupta, A., & Nundy, S. (2005). The private health sector in India. British Medical Journal, 331, 1157–1158.
18
International Journal of Scientific and Innovative Research 2013; 1(1):18-22
FACE RECOGNITION USING NEURAL NETWORK
*SUMAN SHARMA Department of Computer Science, GNIT Institute Greater Noida, U.P., India
Research Scholar, Sai Nath University, Ranchi, India
ABSTRACT Although the distinction between optimum decision and pre-processing or feature extraction is not
essential, the concept of functional breakdown provides a clear picture for the understanding of the
pattern recognition problem. Correct recognition will depend on the amount of discriminating
information contained in the measurements and the effective utilization of this information. In some
applications, contextual information is indispensable in achieving accurate recognition. For instance,
in the recognition of cursive handwritten characters and the classification of fingerprints, contextual
information is extremely desirable. When we wish to design a pattern recognition system which is
resistant to distortions, flexible under large pattern deviations, and capable of self-adjustment, we are
confronted with the adaptation problem. There are many interesting problems that remain in the area
of face recognition.
The information age is quickly revolutionizing the way transactions are completed. Everyday actions are increasingly being handled electronically, instead of with pencil and paper or face to face. This growth in electronic transactions has resulted in a greater demand for fast and accurate user identification and authentication. Access codes for buildings, banks accounts and computer systems often use PIN's for identification and security clearances. Using the proper PIN gains access, but the user of the PIN is not verified. When credit and ATM cards are lost or stolen, an unauthorized user can often come up with the correct personal codes. Despite warning, many people continue to choose easily guessed PIN's. Using the proper PIN gains access, but the user of the PIN is not verified.
When credit and ATM cards are lost or stolen, an
unauthorized user can often come up with the
correct personal codes. Despite warning, many
people continue to choose easily guessed PIN's
and passwords: birthdays, phone numbers and
social security numbers. Recent cases of identity
theft have heightened the need for methods to
prove that someone is truly who he/she claims to
be. Face recognition technology may solve this
problem since a face is undeniably connected to
its owner expect in the case of identical twins. It
is non transferable. The system can then compare
scans to records stored in a central or local
database or even on a smart card. The face is our
19
playing a major role in conveying identity and
emotion. Although, the ability to infer
intelligence or character from facial appearance
is suspect, the human ability to recognize faces
is remarkable. We can recognize thousands of
faces learned throughout our lifetime and
identify familiar faces at a glance even after
years of separation. This skill is quite robust,
despite large changes in the visual stimulus due
to viewing conditions, expression, aging, and
distractions such as glasses, beards or changes in
hair style. Face recognition has become an
important issue in many applications such as
security systems, credit card verification and
criminal identification.
For example, the ability to model a particular
face and distinguish it from a large number of
stored face models would make it possible to
vastly improve criminal identification. Even the
ability to merely detect faces, as opposed to
recognizing them, can be important. Detecting
faces in photographs for automating colour film
development can be very useful, since the effect
of many enhancement and noise reduction
techniques depends on the image content.
Although, it is clear that people are good at face
recognition, it is not at all obvious how faces are
encoded or decoded by the human brain. Human
face recognition has been studied for more than
twenty years.
Unfortunately, developing a computational model of face recognition is quite difficult, because faces are complex, multi-dimensional visual stimuli.
Human face identification is to extract the relevant
features from facial images. Research in the field
primarily intends to generate sufficiently reasonable
familiarities of human faces so that another human can
correctly identify the face. The question naturally
arises as to how well facial features can be quantized.
If such a quantization is possible then a computer
should be capable of recognizing a face given a set of
features. Investigations by numerous researchers over
the past several years have indicated that certain facial
characteristics are used by human beings to identify
faces.
METHODOLOGY OF FACE
RECOGNITION The first method is based on the information theory
concepts, in other words, on the principal component
analysis methods. In this approach, the most relevant
information that best describes a face is derived from
the entire face image. Based on the Karhunen-Loeve
expansion in pattern recognition, M. Kirby and L.
Sirovich have shown that any particular face could be
economically represented in terms of a best coordinate
system that they termed "eigenfaces" These are the
eigenfunctions of the averaged covariance of the
ensemble of faces. Later, M. Turk and A. Pentland
have proposed a face recognition method based on the
eigenfaces approach.
The second method is based on extracting feature
vectors from the basic parts of a face such as eyes,
nose, mouth, and chin. In this method, with the help of
deformable templates and extensive mathematics, key
information from the basic parts of a face is gathered
and then converted into a feature vector L. Yullie and
S.Cohen played a great role in adapting deformable
20
of the thesis we will gather the detailed
information about Face Detection & Recognition
System, how it works, and is it compatible with
our thesis and operating system we are using.
Complete analysis phase can take 2 months. As
our work is completely depended on research
Papers and it is not easy to read and understand
them.
TESTING:
Testing will be done by the developer side &
client side at the end of the final year thesis, as
in our case we are our own clients so we will do
it at our own.
Look at the thesis from a micro level
Include experiments
Look at system results
Test each part of the system
Make sure that design and implementation
works
Identify errors in codes
DEPLOYMENT:
After Completion of coding and testing of the
product, we will deploy the system on our
client’s Place. There are many tools and
techniques that can help in our effort to build
useful, economical, and maintainable systems.
To complete ambitious and complex thesis, we
rely on a wide variety of techniques and Tools
that must work together. C# directly supports a
variety of programming styles. In this, C#
deliberately differs from languages designed to
support a single way of writing programs.
C# language is intended to be a simple, modern,
general-purpose, object-oriented programming
language.
The language, and implementations thereof,
should provide support for software engineering
principles such as strong type checking, array
bounds checking, detection of attempts to use
uninitialized variables, and automatic garbage
collection. Software robustness, durability, and
programmer productivity are important.
The language is intended for use in developing
software components suitable for deployment in
distributed environments.
Source code portability is very important, as is
programmer portability, especially for those
programmers already familiar with C and C++.
Support for internationalization is very
important.
C# is intended to be suitable for writing
applications for both hosted and embedded
systems, ranging from the very large that use
sophisticated operating systems, down to the
very small having dedicated functions.
FEATURES: Object-oriented programming:
The possibility to orientate programming to
objects allows the programmer to design
applications from a point of view more like a
communication between objects rather than on a
structured sequence of code. In addition it allows
a greater reusability of code in a more logical
and productive way.
21
TRAINING AND LEARNING
The decision functions can be generated in a
variety of ways. When complete a priori
knowledge about the patterns to be recognized is
available, the decision function may be
determined with precision on the basis of this
information. When only qualitative knowledge
about the patterns is available, reasonable guesses
of the forms of the decision functions can be
made. In this case the decision boundaries may be
far from correct, and it is necessary to design the
machine to achieve satisfactory performance
through a sequence of Adjustments.
The more general situation is that there exists
little, if any, a priori knowledge about the
patterns to be recognized. Under these
circumstances pattern recognizing machines are
best designed using a training or learning
procedure. Arbitrary decision functions are
initially assumed, and through a sequence of
iterative training steps these decision functions
are made to approach optimum or satisfactory
forms.
It is important to keep in mind that learning or
training takes place only during the design (or
updating) phase of a pattern recognition system.
Once acceptable results have been obtained with
the training set of patterns, the system is applied
to the task of actually performing recognition on
samples drawn from the environment in which it
is expected to operate. The quality of the
recognition performance will be largely
determined by how closely the training patterns
resemble the actual data with which the system will
be confronted during normal operation.
OUTLINE OF A PATTERN RECOGNITION
SYSTEM
In the Figure, functional block diagram of an
adaptive pattern recognition system is shown. One
problem is image pre-processing prior to the
application of the Eigen face method. It may be
possible to gain better accuracy in classification if
one segments the spectrum of people into different
spaces. For example, if one was able to determine
if an image was of a man or a woman, one could
use this categorization to send an image to one of
two classifiers, each specifically trained with that
type of individual in mind. This would mean that
there would be a set of Eigen faces specifically for
males and one specifically for females (face spaces
with gender, so to speak). Work in this area has
been done by Lizama, Waldoestl and Nickolay [4],
however it would be interesting to extend it to use
Eigen faces to act as the gender classifier as well.
A general face-space would be created in addition
to the male and female face-spaces, with the sole
purpose of being used to classify an image as male
or female. Another area of future work is
improving our neural network classifier. As
mentioned previously, it is possible to construct the
network to take its input directly from the image
data rather from the vector that results from an
image projection into face-space. Perhaps learning
the face projection function could increase the
accuracy of the neural network classifier.
Additionally, more experiments are needed to see
if there are other ways to tweak the network
configuration to produce better results.
22
REFERENCE
[1] I. Craw, D. Tock, and A. Bennett, “Finding
face features,” Proc.of 2 nd European Conf.
Computer Vision. pp. 92-96, 1992.
[2] A. Lanitis, C. J. Taylor, and T. F. Cootes, “An
automatic face identification system using flexible
appearance models,” Image and Vision
Computing, vol.13, no.5, pp.393-401, 1995.
[3] T. K. Leung, M. C. Burl, and P. Perona,
“Finding faces in cluttered scenes using random
labeled graph matching,” Proc. 5 th IEEE int’l
Conf. Computer Vision, pp. 637-644, 1995.
[4] B. Moghaddam and A. Pentland,
“Probabilistic visual learning for object
recognition,” IEEE Trans. Pattern Analysis and
Machine Intelligence, vol. 19, no.7. pp. 696-710,
July, 1997.
[5] M. Turk and A. Pentland, “Eigenfaces for
recognition,” J. of Cognitive Neuroscience, vol.3,
no. 1, pp. 71-86, 1991.
[6] M. Kirby and L. Sirovich, “Application of the
Karhunen-Loeve procedure for the
characterization of human faces,” IEEE Trans.
Pattern Analysis and Machine Int
[7] I. T. Jolliffe, Principal component analysis,
New York: Springer-Verlag, 1986.
[8] T, Agui, Y. Kokubo, H. Nagashi, and T.
Nagao, “Extraction of face recognition from
monochromatic photographs using neural
networks,” Proc. 2 nd Int’l Conf. Automation,
Robotics, and Computer Vision, vol.1, pp. 18.81-
18.8.5, 1992.
23
International Journal of Scientific and Innovative Research 2013; 1(1):23-28
A STUDY ON YAMUNA RIVER POLLUTION AGRA TO ETAWAH
*PANKAJ SINDHWAL *Research Scholor, Sai Nath University, Ranchi, India
ABSTRACT
Water pollution is the contamination of water bodies (e.g. lakes, rivers, oceans,
aquifers and groundwater). Water pollution occurs when pollutants are discharged
directly or indirectly into water bodies without adequate treatment to remove harmful
compounds.
Water pollution affects plants and organisms living in these bodies of water. In almost
all cases the effect is damaging not only to individual species and populations, but also
to the natural biological communities.Millions depend on the polluted Yamuna river.
Water is typically referred to as polluted when it is impaired by anthropogenic contaminants and either does not support a human use, such as drinking water, and/or undergoes a marked shift in its ability to support its constituent biotic communities, such as fish. Natural phenomena such as volcanoes, algae blooms, storms, and earthquakes also cause major changes in water quality and the ecological status of water.
Categories
Surface water and groundwater have often been studied and managed as separate
resources, although they are interrelated. Surface water seeps through the soil and becomes groundwater. Conversely, groundwater can also feed surface water sources. Sources of surface water pollution are generally grouped into two categories based on their origin.
Point source water pollution refers to contaminants that enter a waterway from a single, identifiable source, such as a pipe or ditch. Examples of sources in this category include discharges from a sewage treatment plant, a factory, or a city storm drain.
24
Non–point sources
Non–point source pollution refers to diffuse contamination that does not originate from a single discrete source. NPS pollution is often the cumulative effect of small amounts of contaminants gathered from a large area. A common example is the leaching out of nitrogen compounds from fertilized agricultural lands. Nutrient runoff in storm water from "sheet flow" over an agricultural field or a forest are also cited as examples of NPS pollution.
Contaminated storm water washed off of parking lots, roads and highways, called urban runoff, is sometimes included under the category of NPS pollution. However, this runoff is typically channeled into storm drain systems and discharged through pipes to local surface waters, and is a point source.
Groundwater pollution
Interactions between groundwater and surface water are complex. Consequently, groundwater pollution, sometimes referred to as groundwater contamination, is not as easily classified as surface water pollution. By its very nature, groundwater aquifers are susceptible to contamination from sources that may not directly affect surface water bodies, and the distinction of point vs. non-point source may be irrelevant. A spill or ongoing releases of chemical or radionuclide contaminants into soil (located away from a surface water body) may not create point source or non-point source pollution, but can contaminate the aquifer below, defined as a toxin plume. The movement of the plume, called a plume front, may be analyzed through a hydrological transport model or groundwater model. Analysis of groundwater contamination may focus on the soil characteristics and site geology, hydrogeology, hydrology, and the nature of the contaminants.
Causes
The specific contaminants leading to pollution in water include a wide spectrum of chemicals, pathogens, and physical or sensory changes such as elevated temperature and discoloration. While many of the chemicals and substances that are regulated may be naturally occurring (calcium, sodium, iron, manganese, etc.) the concentration is often the key in determining what is a natural component of water, and what is a contaminant. High concentrations of naturally occurring substances can have negative impacts on aquatic flora and fauna.
Oxygen-depleting substances may be natural materials, such as plant matter (e.g. leaves and grass) as well as man-made chemicals. Other natural and anthropogenic substances may cause turbidity (cloudiness) which blocks light and disrupts plant growth, and clogs the gills of some fish species.
Many of the chemical substances are toxic. Pathogens can produce waterborne diseases in either human or animal hosts. Alteration of water's physical chemistry includes acidity (change in pH), electrical conductivity, temperature, and eutrophication. Eutrophication is an increase in the concentration of chemical nutrients in an ecosystem to an extent that increases in the primary productivity of the ecosystem. Depending on the degree of eutrophication, subsequent negative environmental effects such as anoxia (oxygen depletion) and severe reductions in water quality may occur, affecting fish and other animal populations.
Pathogens
A manhole cover unable to contain a sanitary
sewer overflow.
25
Coliform bacteria are a commonly
used bacterial indicator of water pollution,
although not an actual cause of disease.
Other microorganisms sometimes found in
surface waters which have caused human
health problems include:
Burkholderia pseudomallei
Cryptosporidium parvum
Giardia lamblia
Salmonella
Novovirus and other viruses
Parasitic worms (helminths).
High levels of pathogens may result from
inadequately
treated sewage discharges.[14] This can be
caused by a sewage plant designed with less
than secondary treatment (more typical in less-
developed countries). In developed countries,
older cities with aging infrastructure may have
leaky sewage collection systems (pipes, pumps,
valves), which can cause sanitary sewer
overflows. Some cities also have combined
sewers, which may discharge untreated sewage
during rain storms.
Pathogen discharges may also be caused by
poorly managed livestock operations.
Muddy river polluted by sediment.
Contaminants may
include organic and inorganic substances.
Organic water pollutants include:
Detergents Disinfection by-products found in
chemically disinfected drinking water, such as chloroform
Food processing waste, which can include oxygen-demanding substances, fats and grease
Insecticides and herbicides, a huge range of organ halides and other chemical compounds
Petroleum hydrocarbons, including fuels (gasoline, diesel fuel, jet fuels, and fuel oil) and lubricants (motor oil), and fuel combustion byproducts, from storm water runoff
Tree and bush debris from logging operations
Volatile organic compounds (VOCs), such as industrial solvents, from improper storage.
Chlorinated solvents, which are dense non-aqueous phase liquids (DNAPLs), may fall to the bottom of reservoirs, since they don't mix well with water and are denser.
Polychlorinated biphenyl (PCBs) Trichloroethylene Perchlorate
Many chemicals undergo reactive decay or chemically change especially over long periods of time in groundwater reservoirs. A noteworthy class of such chemicals is the chlorinated hydrocarbons such as trichloroethylene (used in industrial metal degreasing and electronics manufacturing) and tetra choloro ethylene used in the dry cleaning industry (note latest advances in liquid carbon dioxide in dry cleaning that avoids all use of chemicals).
26
Both of these chemicals, which are carcinogens themselves, undergo partial decomposition reactions, leading to new hazardous chemicals (including dichloro ethylene and vinyl chloride).
Groundwater pollution is much more difficult to abate than surface pollution because groundwater can move great distances through unseen aquifers. Non-porous aquifers such as clays partially purify water of bacteria by simple filtration (adsorption and absorption), dilution, and, in some cases, chemical reactions and biological activity: however, in some cases, the pollutants merely transform to soil contaminants. Groundwater that moves through cracks and caverns is not filtered and can be transported as easily as surface water. In fact, this can be aggravated by the human tendency to use natural sinkholes as dumps in areas of Karst topography.
There are a variety of secondary effects stemming not from the original pollutant, but a derivative condition. An example is silt-bearing surface runoff, which can inhibit the penetration of sunlight through the water column, hampering photosynthesis in aquatic plants.
Measurement
Environmental Scientists preparing water auto samplers.
Water pollution may be analyzed through several broad categories of methods: physical, chemical and biological. Most involve collection of samples, followed by specialized analytical tests. Some methods may be conducted in situ, without sampling, such as temperature. Government agencies and research organizations have published standardized, validated analytical test methods to facilitate the comparability of results from disparate testing events.
Sampling
Sampling of water for physical or chemical testing can be done by several methods, depending on the accuracy needed and the characteristics of the contaminant. Many contamination events are sharply restricted in time, most commonly in association with rain events. For this reason "grab" samples are often inadequate for fully quantifying contaminant levels. Scientists gathering this type of data often employ auto-sampler devices that pump increments of water at either time or discharge intervals.
Sampling for biological testing involves collection of plants and/or animals from the surface water body. Depending on the type of assessment, the organisms may be identified for bio surveys (population counts) and returned to the water body, or they may be dissected for bioassays to determine toxicity.
Physical testing
Common physical tests of water include
temperature, solids concentrations (e.g., total
suspended solids (TSS)) and turbidity.
Chemical testing
Water samples may be examined using the
principles of analytical chemistry. Many
published test methods are available for both
organic and inorganic compounds. Frequently
used methods include pH, biochemical oxygen
demand (BOD), chemical oxygen demand (COD),
nutrients nitrate and phosphorus compounds),
metals (including copper, zinc, cadmium, lead and
mercury), oil and grease, total petroleum
hydrocarbons (TPH), and pesticides.
27
Biological testing
Biological testing involves the use of plant, animal, and/or microbial indicators to monitor the health of an aquatic ecosystem.
Control of pollution
Domestic sewage
Domestic sewage is 99.9 percent pure water, while the other 0.1 percent are pollutants. Although found in low concentrations, these pollutants pose risk on a large scale. In urban areas, domestic sewage is typically treated by centralized sewage treatment plants. In the U.S., most of these plants are operated by local government agencies, frequently referred to as publicly owned treatment works (POTW). Municipal treatment plants are designed to control conventional pollutants: BOD and suspended solids. Well-designed and operated systems (i.e., secondary treatment or better) can remove 90 percent or more of these pollutants. Some plants have additional sub-systems to treat nutrients and pathogens. Most municipal plants are not designed to treat toxic pollutants found in industrial wastewater.
Cities with sanitary sewer overflows or combined sewer overflows employ one or more engineering approaches to reduce discharges of untreated sewage, including:
utilizing a green infrastructure approach to improve storm water management capacity throughout the system, and reduce the hydraulic overloading of the treatment plant
repair and replacement of leaking and malfunctioning equipment
increasing overall hydraulic capacity of the sewage collection system (often a very expensive option).
A household or business not served by a municipal treatment plant may have an individual septic tank, which treats the wastewater on site and discharges into the soil. Alternatively, domestic wastewater may be sent to a nearby privately owned treatment system (e.g. in a rural community).
Industrial waste water Dissolved air flotation system for treating industrial wastewater.
Some industrial facilities generate ordinary domestic sewage that can be treated by municipal facilities. Industries that generate wastewater with high concentrations of conventional pollutants (e.g. oil and grease), toxic pollutants (e.g. heavy metals, volatile organic compounds) or other nonconventional pollutants such as ammonia, need specialized treatment systems. Some of these facilities can install a pre-treatment system to remove the toxic components, and then send the partially treated wastewater to the municipal system. Industries generating large volumes of wastewater typically operate their own complete on-site treatment systems.
Water Environment
The existing scenario of water environment essentially deals with the availability of water resources of acceptable quality and the prevailing quality of utilization pattern. The water resources of the region depend on the participation and the water available from the adjoining region by way of surface water flows through canals. The recharge potentials of groundwater reserves also influence the availability of annual utilizable groundwater resources. The water resources are thus influenced by climate, physiography and hydrogeology of the region.
28
Assimilative capacity of water bodies is defined as maximum amount of pollutant load that can be discharged without impairing water quality for their designated best usage. The basic phenomenon governing the assimilative capacity of water sources is the self- purification capacity.
Sources of Water Pollution
(a)Point sources
The two major point sources of pollution in water bodies in study area are municipal and industrial wastes.
(b)Non-point Sources
Run off from rural settlement and agricultural fields is a major nonpoint sources of water pollution due to the excessive use of chemical fertilizers and pesticides for agriculture, the prevailing practices of open defecation and cattle swimming or wallowing. Inadequate solid waste handling and disposal systems in most of the towns further add to the problems.
Status and Assessment of Water Quality
Water quality and the aquatic environment are
closely related. Both are strongly influenced by
water quantity and all three are interrelated with
land use. Urban development altered vegetarian
cover and other human activities create point
and diffuse sources of pollution and change the
run off regime, adversely affecting the quality,
quantity and seasonal availability of water.
Water resource developments also have adverse
impacts, to varying degrees depending on the
nature.
Water Quality Parameter
Water the most vital resource for all kinds of life on this planet is also the resources, adversely affected both qualitatively and quantitatively by all kinds of human activities or land, in air or in water.
Temperature :-
The parameter of temperature is basically important for its effects on the chemistry, and biological reactions in the organisims in water. A rise in temperature of the water leads to the seeding up of the chemical reactions in water reduce s the solubility of gases and amplifies the tastes and ordours. Water in the temperature range of 70C to 110C has a pleasant taste and is refreshing. At higher temperature with less dissolved gases, the water becomes tasteless and even does not quench the thirst. At elevated temperatures, metabolic activity of the organisms increases, requiring more oxygen but at the same time the solubility of oxygen decreases, thus accentuating the stress Organisms in water have varying sensitivities to temperature. The organisms with a high resistance to temperature fluctuations are called ‘eurythermic’ while the organisms with low tolerance are referred as ‘stenothermic’ .The disease resistance in the fishes also decreases with the rise in temperature.
Temperature is also very important in the determination of various other parameters such as pH, conductivity, saturation level of gases and various forms of alkalinity, etc. Data on temperature is also required by the industries in heat transmission calculations, cooling tower and process use.
29
International Journal of Scientific and Innovative Research 2013; 1(1):29-32 COMPARATIVE STUDY OF FDIs AND FIIs IN THE INDIAN CONTEXT”
*YOGENDRA SAMEER YADAV
*Research scholor, Sai Nath University, Ranchi, India
ABSTRACT
The Indian stock exchanges hold a place of prominence not only in Asia but also at the global
stage. The foreign direct investment (FDI) and foreign institutional investment (FII)) have played
an important role in the process of development of many economies. Further, many developing
countries consider foreign direct investment (FDI) and foreign institutional investment (FII) as
an important element in their development strategy among the various forms of foreign
assistance.
The Foreign direct investment (FDI) and foreign institutional investment (FII) flows are usually
preferred over the other form of external finance, because they are not debt creating, nonvolatile
in nature and their returns depend upon the projects financed by the investor. The Foreign direct
investment (FDI) and foreign institutional investment (FII) would also facilitate international
trade and transfer of knowledge, skills and technology.
The Foreign direct investment (FDI) and foreign institutional investment (FII) are the process
by which the resident of one country (the source country) acquires the ownership of assets for
the purpose of controlling the production, distribution and other productive activities of a firm
in another country.
30
RESEARCH METHODOLOGY The lifeblood of business and commerce in the modern world is information. The ability to gather, analyze, evaluate, present and utilize information is therefore is a vital skill for the manager of today. In order to accomplish this project successfully I will take following steps. HYPOTHESIS: The researcher assumes if the hypothesis holds good then we can infer that FIIs have significant impact on the Indian capital market. This will help the investors to decide on their investments in stocks and shares. NULL HYPOTHESIS (Ho): There is no influence of FIIs on the Stock indexes. ALTERNATIVE HYPOTHESIS (Ho): There is an influence of FIIs on Stock indexes. If we reject the Ho, then we accept the Ho, setting the significance level to 5% and 1% 1) SAMPLING- The study is limited to a sample of top 10 investing countries e.g. Mauritius, USA etc. and top 10 sectors e.g. electrical instruments, telecommunications etc. which had attracted larger inflow of FDI and data of NSE stock exchange will be taken to know the impact of FII. 2) DATA COLLECTION ➢ The research will be done with the help Secondary data (from internet site and journals). ➢The data is collected mainly from websites, annual reports, World Bank reports, research reports, already conducted survey analysis, database available etc.
3) ANALYSIS: Appropriate Statistical tools like correlation and regression will be used to analyze the data like to analyze the growth and patterns of the FDI and FII flows in India during the post liberalization period, the liner trend model will be used. Further the percentage analysis will be used to measure the share of each investing countries and the share of each sectors in the overall flow of FDI and FII into India. 1) Impact of FIIs on Sensex: In 2007, the correlation coefficient is more than in 2008 which interprets that the relationship between these two variables is more in the period when there is bearish trend. But in both the years FIIs were not much positively correlated, so a less significant impact of FIIs is seen. The error is very high in both the years which doesn’t mean that relation is false but we can say that the error in linear relation is high. 2) Impact of FIIs on Nifty: The correlation coefficient of FIIs and Nifty is unrelated in 2007 and 2008. The regression coefficient predicts the value from an independent variable i.e. FII for the dependent variable Nifty. Regression coefficient is 0.26 in 2008 and 0.91 in 2007 which replicates that how Nifty index has gone down by withdrawal of FIIs.
31
3) Impact of FIIs on Industrial Sectoral Indices: In different Industrial sectoral indices of BSE ( BSE Auto, BSE Banking, BSE CD, BSE FMCG, BSE Realty) the correlation is always less. And also the coefficient of determination reveals that the explained variance ( FII ) doesn’t has much impact on the sectoral indices. And in 2008 the regression coefficient is giving a clear picture that the withdrawal by FIIs is resulting a fall in indices and so FIIs are playing good role during this time. 4) FIIs have less impact on Indian stock indices and other unexplained variables are also influencing the Indices. 5) In bearish trend of 2008 the volatility in Indian Stock indices due to FIIs is more than in bullish trend of 2007. No doubt FII inflow is more in 2007. The domestic investors were also playing an important role in 2007 but in 2008 FIIs is influencing market more as domestic investors are not in the market. CONCLUSION In developing countries like India foreign capital helps in increasing the productivity of labour and to build up foreign exchange reserves to meet the current account deficit. Foreign Investment provides a channel through which country can have access to foreign capital.
According to data analysis and findings, it can be concluded that FII do have any significant impact on the Indian Stock Market but there are other factors like government policies, budgets, bullion market, inflation, economical and political condition, etc. do also have an impact on the Indian stock market. There is a positive correlation between stock indices and FIIs but FIIs didn’t have any significant impact on Indian Stock Market. The null hypothesis is rejected. BSE CD and Nifty showed some positive correlation with FII in 2007 and 2008 but rest of the indices showed very less positive correlation with FII. Also the coefficient of determination is less in all the case. It shows the absence of linear relation between FII and stock index. This does not mean that there is no relation between them. One of the reasons for absence of any linear relation can also be due to the sample data. The data was taken on monthly basis. The data on daily basis can give more positive results (may be). Also FII is not the only factor affecting the stock indices. There are other major factors that influence the bourses in the stock market.
32
REFERENCE
1. Andy Lin Chih-Yuan Chen (2006): “The Impact of Qualified Foreign Institutional Investors on Taiwan’s Stock Market”, Journal : Journal of FII , their flow to India and Government policies Vol 23. Publisher: SSRN Group Publishing Limited.
2. Arshanapalli Bala and Kulkarni Mukund S. (1997) : “Impact of U.S. stock market on Indian stock markets”, Journal: International Journal of market fluctuations in stock market, Vol: 11. Publisher: MCB UP Ltd.
3. Bose Suchismita and Coondoo Dipaankar (2005): “The Impact of FII Regulations in India”, Journal: International Journal of financial market trends. Vol 30. Publisher: MCB UP Ltd Chakrabarti (2001), Journal: Journal of foreign institution investments Vol 27. Publisher: SSRN Group Publishing Limited.
4. David carpenter Partner Mayer, Brown, Rowe & Maw LLP (2005): “Foreign Investment in India” Journal: Journal of financial research. Vol 19.Publisher: MCB UP Ltd
5. Ilangovan Prof. D. & Mr. Tamilselvan M. (1997) : “Extra Mileage In Foreign Investment in Resurging India”, Journal: International Journal of foreign money supply Management, Vol: 28. Publisher: MCB UP Ltd.
6. www.bseindia.com 7. www.nseindia.com 8. www.sebi.org. 9. www.rbi.org
33 | P a g e
International Journal of Scientific and Innovative Research 2013; 1(1):33-35
ENVIRONMENTAL AWARENESS ON VALUE BASED
EDUCATION IN SCHOOLS, COLLEGES AND UNIVERSITIES AS
PART OF TEACHER’S TRAINING PROGRAMME
1. BRIJESH CHANDRA TRIPATHI
*,
2. MANJUSHA AWASTHI
1. Deptt. of Education, Rama Mahavidyalaya Chinhat, Lucknow.U.P., India
2. Research Scholar, Sai Nath University, Ranchi, India
*Corresponding Author
Our present generation is confused about their
values because of double standard of practices by
people in position of power and break down of
traditional values without proper replacement.
This confusion may be removed by education
because it is through education that society seeks
to promote and preserve its cherished values.
Education is man making and character building
programme as well as the training of body, mind,
soul. Education is an instrument of social change
and national development and perfection and
excellence.
A new dimension has been begin to appear in the
last few years as the impact of man and his
activities of nature come to be noted. The impact
of human activity on our physical and biological
environment has a consequential effect on man.
Advancement of Science and Technology has
added to the man comforts by giving is
automobiles, electric appliances, supersonic jets,
space crafts, better medicine, better chemicals to
control harmful insects and better fertilizers etc,
but in the other hand people have given us a very
serious problem to face pollution. When highest
animals and man began their life on this earth,
there was perfect balance in various natural
process and with this also increased the various
pollution areas as water, soil noise and food
pollution.
The air and water were pure and soil was fertile.
The problem of pollution arouse with the very
civilization the air pollution began. The pollution
was increased in our working sphere.
The pollution of various resources has gone to
such an extent that we are unable to breath fresh
air, to drink fresh water and take pure food. It is
accepted, the alternate good of education is to
living better life. If aim of education is to living
better life including such values in person so that
environmental awareness may be developed.
The schools, colleges and universities will have
to bear the responsibilities in developing the
environmental awareness among students
through environmental education.
Environmental education covers the study of all
systems of air, land, water energy and busy life
that surrounded by man.
Regarding this, in 1995 UGC constituted three
groups to develop textual material core general
environmental education and environment of
public awareness programme for universities
and training
34 | P a g e
colleges. One specially requested to make
environmental education on a compulsory
course as a part of the foundation course at
school and college level.
The objectives of Environmental
Education are fallowing:-
1. The public teacher will be able to
acquire basic knowledge about various
aspects of environment and
environmental education.
2. Become aware and sensitive towards
environment and its allied problems.
3. Become concerned about urgent action
for environmental protection and
conservation.
4. Get oriented with the concept, methods
and activities regarding environmental
education.
(i) Awareness
(ii) Knowledge
(iii) Participation
The specific aims:-
1. Cognitive Aims:-These include about
environment an imparting knowledge
and an ability to think which will able
the individual and social group to work.
2. Normative Aims:- To inculcate the
ecological awareness which will be
conducting to the creation the
modification on model enabling the
individual and group of identity of
factors that upset the environmental
equilibrium protest against them.
3. Technical Aims to restore:-The
quality of life as understood by the
community light of formal and informal
education in such a way that depends on
ecosystem.
There are three main aims of
environmental education:-
The specific aims:-
1. Cognitive Aims:-These include about
environment an imparting knowledge and
an ability to think which will able the
individual and social group to work.
2. Normative Aims:- To inculcate the
ecological awareness which will be
conducting to the creation the
modification on model enabling the
individual and group of identity of
factors that upset the environmental
equilibrium protest against them.
3. Technical Aims to restore:-The quality
of life as understood by the community
light of formal and informal education in
such away that depends on ecosystem.
Teaching of environmental education
course contents and help in the deter
monition of the guiding principles of this
course is relevant to keep the salient
features of this new academic discipline
in the mind some guidelines and norms
which stimulate education and attract
their interests are:-
1. The environmental education should
be a continuous life long process
beginning at preschool level and
continuing through all formal and non
formal stages of education.
2. Environmental education should
examine major environmental
necessity, local, national, regional and
international point of view.
35 | P a g e
3. Environmental education should
explicitly consider environmental
aspects in planning for development
and growth.
4. Environmental education should relate
environmental sensitive knowledge and
problem solving skill to every stage
about environmental issues.
5. Environmental Education should
emphasize the complexity and
interrelated environmental problems.
The schools, college and universities
have real stake in this awareness
generation programme. This
programme cannot continue without
the active and alert support of all
educational practices, administrators
and educationists.
REFERENCE
1.Gruenewald, D.A. 2004, A foundation of
environmental education towards the
socio logical challenge of the earth
charter, Curriculum inquiry 34 (i) PP. 71-
72
2.Malone K. 1999. Environmental
education Researchers as environmental
activists, environmental education
Research 5(2) pp. 163-177.
Mongu G.S., 2001 Environment and
Development Deep and Deep publication
Pvt. Ltd. New Delhi.
3.Rajput Arla, 2001 Environmental
education Encyclopedia of Indian
education Volume NCERT New Delhi
pp. 659-663.
4.Sharm R.A. Environmental
education Surya PublicationMeerut. PP.
444.
5.Neetam, 2008, ShikshalShodhPalrika Val
(2)-(1) pp. 84-88.
6.Srivastava V.P. Chandra M. (2003)
Environmental education :- Issues and
concern NCERT New Delhi.
7.UGC 2001 :Model curriculum of
Secondary Teacher education programme
UGC New Delhi.
International Journal of Scientific and Innovative Research 2013;1(1) P-ISSN 2347-2189, E- ISSN 2347-4971
www.ijsir.co.in 155
INTERNATIONAL JOURNAL OF SCIENTIFIC &
INNOVATIVE RESEARCH
(A Bi-annual Official Journal of Sky Institute, a constituent Institution of BALA JI FOUNDATIONestablished under Societies Registration Act 1860)
AIM & SCOPE
The International Journal of Scientific & Innovative Research (IJSIR)is a bi-annual published online/ offline journal which publishes innovative research papers, reviews, mini reviews, shortcommunications and notes dealing with all branches of science, technology, engineering health andagriculture. All manuscripts are subject to rapid peer review, those of high quality (not previouslypublished and not under consideration for publication in another journal) contributing significantly tofurther the scientific knowledge in science, technology, engineering, health and agriculture will bepublished without delay. The subjects will cover all the disciplines and branches of science, technology,
engineering, health and agriculture.
EDITORIAL POLICY
The criteria for publication are originality high scientific quality and interest to a multidisciplinaryaudience. Papers not sufficiently substantiated by experimental detail will not be published. Anytechnical queries will be referred back to the author although the Editors reserve the right to makealterations in the text without altering the technical content. Manuscripts submitted under multipleauthorships are reviewed on the assumption that all listed authors concur with the submission andthat a copy of the final manuscript has been approved by all authors. If accepted, the manuscriptsshall not be published elsewhere in the same form in either the same or another language withoutthe consent of the Editors.
International Journal of Scientific and Innovative Research insists on ethical practices in both humanand animal experimentation. Evidence for approval by a institutional Ethics Committee (for bothhuman as well as animal studies) must be supplied by the authors on demand. Animal experimentalprocedure should be on humane as possible and the details of anesthetics and analgesics usedshould be clearly stated. The ethical standards of experiments must be in accordance with theguidelines provided by the CPCSEA (animal) and ICMR (human). The journal will not consider anypaper which is ethically unacceptable. A statement on ethics committee permission must be includedin all research articles under the Materials and Methods section. Authors must be careful when theyreproduce text, tables and illustrations from other sources. Plagiarism will be viewed seriously. Allaccepted papers are subject to editorial changes. All rights are reserved to editor-in-chief, InternationalJournal of Scientific & Innovative Research (IJSIR). IJSIR will be published bi-annually in the month ofJuly (January-June issue) and January (July-December issue) every year.
IJSIR would take much care in making your article published without much delay with your kind co-
operation.
• A Broad ranging open access journal.• Fast and efficient online submission.• Expert peer review.• Rapid publications and high visibility.• Cost saving.• Ability to track the publication processing progress.
• Ease of contacting the IJSIR Journal
156 www.ijsir.co.in
International Journal of Scientific and Innovative Research 2013;1(1)) P-ISSN 2347-2189, E- ISSN 2347-4971
INSTRUCTION TO AUTHORS
The International Journal of Scientific and Innovative Research is a bi-annually published online/ offline Journal which publishes innovative research papers, reviews, mini-reviews, shortcommunications and notes dealing with all branches of science, technology and engineering, healthand agriculture. All manuscripts are subject to rapid peer review. Those of high quality (not previouslypublished and not consideration for publication in another journal) will be published without delay.
MANUSCRIPT FORMAT
The preferred format of all manuscript is MS Word or RTF. Illustrations (figures) and imagesmust be inserted in the manuscript at the position they should appear when published.
PREPARATION OF MANUSCRIPTS
RESEARCH PAPER
The language of the journal is English. Each manuscript should be typed double-spaced on A4(8.5" x 11") paper size with 1 inch margins. It should be arranged in the following order: Title, Abstract,Keywords, Introduction, Materials and Methods, Results, Conclusion, Acknowledgement, References.
Title Page
Title page should contain title of the paper in bold face, title case (font size 14), names of theauthors in normal face, upper case (font size 12) followed by the address in normal face lower case.The author to whom all correspondence be addressed should be denoted by an asterisk mark. Thetitle should be as short as possible and precisely indicate the nature of the work in the communication.Names of the authors should appear as initials followed by surnames. At the bottom left corner of thetitle page, please mention “*Address For correspondence” and provide a functional e-mail address.Address of the corresponding author to whom all correspondence may be sent should be given onlyif is different from the address already given under author’s names.
Abstract
Should start on a new page after the title page and should be typed in single-space to distinguishit from the Introduction. Abstracts should briefly reflect all aspects of the study, as most databases listmainly abstracts.
Key-words
Provide four to six appropriate key words after abstract.
Introduction
Shall start immediately after the abstract, as the next paragraph, but should be typed in double-space. The Introduction should lead the reader to the importance of the study; tie-up publishedliterature with the aims of the study and clearly states the rationale behind the investigation.
Materials and Methods
Shall start as a continuation to introduction on the same page. All important materials usedalong with their source shall be mentioned. The main methods used shall be briefly described, citingreferences. Trivial details may be avoided. New methods or substantially modified methods may bedescribed in sufficient detail. The statistical method and the level of significance chosen shall beclearly stated. IJSIR prefers to publish work that has been subjected to an appropriate statistical testat one level of significance.
International Journal of Scientific and Innovative Research 2013;1(1) P-ISSN 2347-2189, E- ISSN 2347-4971
www.ijsir.co.in 157
Results
All findings presented in tabular or graphical form shall be described in this section. The datashould be statistically analyzed and the level or significance stated. Data that is not statisticallysignificant need only to be mentioned in the text – no illustration is necessary. All tables and figuresmust have a title or caption and legend to make them self-explanatory. Results section shall startafter materials and methods section on the same page.
Discussion
This section should follow results, deal with the interpretation of result, convey how they helpincrease current understanding of the problem and should be logical. Unsupported hypothesis shouldbe avoided. The Discussion should state the possibilities the results uncover that need to be furtherexplored. There is no need to include another title such as “Conclusions” at the end of Discussion.Results and discussion of results can also be combined under one section, Results and Discussion.
Acknowledgements
Should be given after the text and not in the form of foot-notes.
References
Should be numbered consecutively in the order in which they are first mentioned in the text (notin alphabetic order). Identify references in text, tables and legends by Arabic numerals in superscriptin square brackets. References cited only in tables or figure legends should be numbered inaccordance with the sequence established by the first identification in the text of the particular tableor figure.
Journal Articles
Singh N., Verma P., Pandey B.R., Gilca M. Role of Withania somnifera in Prevention and Treatmentof Cancer: An Overview. International Journal of Pharmaceutical Sciences and Drug Research. 2011;3(4): 274-279.
A Book
Singh N, Gilca M. Herbal Medicine – Science embraces tradition – a new insight into the ancientAyurveda. Edn 1, Lambert Academic Publishing (Germany), 2010, pp. 115-116.
A chapter in a Book
Nadkarni KM, Indian Materia Medica. Edn 3, Vol. I, Popular Prakashan, Mumbai, 2000, pp. 242-246.
A Report
World Health Organization. The World Health Report 2004: changing history.Geneva: WHO; 2004.
Conference Proceedings
Stock A, Signal Trasduction in Bacheria. In the Proceedings of the 2004 Markey ScholarsConference. 2004, pp. 80-89.
A Thesis
Strunk, JL. The extraction of mercury from sediment and the geochemical partitioning of mercuryin sediments from Lake Superior, M.S. thesis, Michigan State Univ. East Lansing, Ml, 1991
Illustrations
Tables – Should be typed on separate sheets of paper and should not preferably contain any
158 www.ijsir.co.in
International Journal of Scientific and Innovative Research 2013;1(1)) P-ISSN 2347-2189, E- ISSN 2347-4971
molecular structures. Only MS word table format should be used for preparing tables. Tables shouldshow lines separating columns but not those separating rows except for the top row that showscolumn captions. Tables should be numbered consecutively in Arabic numerals and bear a brief titlein capital letters normal face. Tables should not be very large that they run more than one A4 sizedpage.
Figures
Should be on separate pages but not inserted within the text. Figures should be numberedconsecutively in Arabic numerals and bear a brief title in lower case bold face letters below the figure.Graphs and bar graphs should preferably be prepared using Microsoft Excel and submitted as Excelgraph pasted in MS Word.
Abbreviations, Units Etc
Authors should follow internationally agreed rules especially those adopted by the IUPAC-IUBCommission on Biochemical Nomenclature (CBN). The journal will essentially follow the rules definedin the IUPAC Manual of symbols and terminology for physico-chemical quantities and units.
Short Communications
The journal publishes exciting findings, preliminary data or studies that did not yield enoughinformation to make a full paper as short communications. These have the same format requirementsas full papers but are only up to 10 pages in length in total. Short Communications should not havesubtitles such as Introduction, Materials and Methods, Results and Discussion – all these have to bemust into the running text. Short Communications preferably should have only 3-4 illustrations.
Review Articles
Should be about 15-30 pages long, contain up-to-date information, comprehensively coverrelevant literature and preferably be written by scientists who have in -depth knowledge on the topic.All format requirements are same as those applicable to full papers. Review articles need not bedivided into section such as materials and methods and results and discussions, but should definitelyhave an abstract and introduction if necessary.
Submission of Manuscript
All manuscripts (must be in English and in MS Word format) and should be submitted via ouronline system or through e-mail [email protected], as an attachment for quick evaluation.
Manuscript Charges
There is no charge for the processing of papers but author(s) of each accepted paper is requiredto pay a publication charge of Rs. 2,000 for Indian authors and US $ 125 for foreign authors beforethe accepted paper is published.
Copyright and Permissions
Submission is a representation that the manuscript has not been published previously and isnot under consideration for publication elsewhere. Authors would be required to sign a form (to besupplied by the Editor) transferring copyright before the manuscript can be published. By submittinga manuscript to the editor or publisher you are deemed to have granted permission to publish themanuscript.
Ethical Matters
Authors using experimental animals and human subjects in their investigation must seek approvalfrom the appropriate Ethical Committee. The method section must include a statement to prove that
International Journal of Scientific and Innovative Research 2013;1(1) P-ISSN 2347-2189, E- ISSN 2347-4971
www.ijsir.co.in 159
the investigation was approved and that informed consent was obtained.
Galley Proofs
Proofs will sent via e-mail as an Acrobat PDF (Portable Document Format) file. Acrobat Reader willbe required in order to read the PDF.
Manuscript Submission Process:
1. First you should Read “Author Instructions” and
2. Download “Cover letter” -fill the necessary fields and scan it and send to our email addressalong with manuscript or Upload through Online Manuscript submission option.
3. Submit your prepared manuscript through email or Online submission option.
4. Download “Copy Right Form” and Sign it (by the corresponding/main author) and sendits scanned copy only to Email ID [email protected].
(Without this signed undertaking your paper would not getdisplayed.)
Track Your Manuscript: New Option of our IJSIR web portal.
You can track the status of your manuscript through the online production process. Please provideyour Manuscript ID to know the status.
160 www.ijsir.co.in
International Journal of Scientific and Innovative Research 2013;1(1)) P-ISSN 2347-2189, E- ISSN 2347-4971
COVER LETTER
Date
Place
From
(Name and Address of the corresponding author)
To,
Editor-in-Chief
International Journal of Scientific and Innovative Research (IJSIR)
Sir,
Ref: Title
Type
Subject
Branch
In reference to the above title, I as a corresponding author submit the manuscript for
publication in International Journal of Scientific and Innovative Research. I undertake that
animal study (if any) was taken after the prior approval of country/institutional ethical committee.
This manuscript has not been published or considered for publication by any other journal or
elsewhere. Kindly consider the manuscript for publication in your journal.
Thank you
Corresponding author name
International Journal of Scientific and Innovative Research 2013;1(1) P-ISSN 2347-2189, E- ISSN 2347-4971
www.ijsir.co.in 161
PRINT SUBSCRIPTION RATES
International Journal of Scientific and Innovative Research (IJSIR)
SUBSCRIPTION FORM
Complete and submit this form to order an individual /institutional subscription for the print version ofthe International Journal of Scientific and Innovative Research (IJSIR), a bi- annual journal. The
journal is published in month of July (January-June) and January (July-December) every year.
Select Your Subscription:
• Individual Subscription• Institutional Subscription
Note: Subscriber should submit the subscription form to email ID: [email protected]
Subscriber’s Name: (It includes first name, last name and professional credential (if any)
NAME …………………….......................................................................................……………………
INSTITUTIOANAL/ INDIVIDUAL ADDRESS .…………................................…………………………….
…………………………………………………......................................................................................…
STATE …………………………………..............……… CITY……...................……………………………
PIN CODE ……………................... COUNTRY………….................................…………………………
PHONE NUMBER(S) ………........................................................................……..……………………
E-MAIL ADDRESS………………........................................................................………………………
PAYMENT DETAILS:
• BANK NAME …………………..............................................……………………………
• DD NO/ CHEQUE NO ……….......................................DATE…………..………………
• AMOUNT………………...............................................…………………………………..
SUBSCRIPTION RATE
• FOR INDIVIDUAL – 3000/- OR 200 US$ FOR FIVE YEAR
• FOR INSTITUTION- 5000/- OR 250 US$ FOR FIVE YEAR
Payment should be made in favor of BALAJI FOUNDATION, payable at LUCKNOW.NOTE: Fees once paid will not be refunded in any circumstances.
SIGNATURE
162 www.ijsir.co.in
International Journal of Scientific and Innovative Research 2013;1(1) P-ISSN 2347-2189, E- ISSN 2347-4971
UNDERTAKING*
I _____________________________________________________________ (corresponding
author), working as __________________ (Designation), in __________________(Department/
Affil iation), do hereby submit the manuscript No. _____ entitled:
______________________________________, authors _________, _____________,
_______________ (names of all authors) for publication in International Journal of Scientific
and Innovative Research.
I / We declare that this is an original research work and is not previously published or presentedelsewhere in any language and is also not in consideration in any other journal simultaneously.
I /we, all authors of the above manuscript are agree that the content of this manuscript will notbe copyrighted, submitted, or published elsewhere (including the internet), and is also not plagiarizedfrom any language.
I/We also solemnly affirm that not any brand name of drug/product/manufacturer was includedin this manuscript to avoid legal hindrance and I / We will responsible to face any dispute, pointed outby anyone in future.
Name with designation/affiliation
of the corresponding author
Name of all author Signature Affiliation
1.____________________________________ ________________ __________________
2.____________________________________ ________________ __________________
3.____________________________________ ________________ __________________
*This undertaking must be submitted along with submission of the manuscript in IJSIR.